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- A chioroquine-resistant parasite line of Plasmodium chabaudi 
was obtained by submitting a- sensitive line to a continuous 
and gradually increasing level of drug-pressure. 	The line 
411AS survived treatment of 3 mg/kg given for 6 days which 
eliminates the original drug sensitive line. 
Cyclical transmission of 411AS as well as stability studies 
carried out showed that resistance was stable and transmissible 
through mosquitoes in the absence of drug pressure. 	 - 
The genetic basis of chioroquine resistance was studied by 
making a cross between 411AS and a sensitive line of different 
origin, 96AJ, which differed additionally in 3 characters. 
Seventy clones from this cross were classified. 	Various re- 
combinant classes were obtained and the results showed that 
chloroquine resistance in P. chabaudi is a stable character 
which undergoes genetic recombination with other markers. 
Another line, 524AJ, resistant to 3 mg of chloroquine/kg ad-
ministered for 6 days,. was obtained by similar low drug 
pressure method. 
Cyclical transmission of 524AJ and from clones established 
from this population showed that this line exhibited two types 
of resistance: (a) a stable, heritable form detectable after 
mosquito transmission, and (b) an unstable form which could 
not be detected after mosquito transmission. 
6.! 
6. 	Competition studies between chioroquine-resistant and 
chioroquine-sensitive parasites were made by mixing differ-
ent proportions of blood forms in mice and by establishing 
and testing clones at different stages of the infection. 
Sporozoites from mosquitoes which fed on each mixture were 
also used to establish new infections in mice and clones 
were established and tested in a similar way. 	All the 
experiments showed an apparent selective advantage of the 
resistant over the sensitive forms in the absence of chloro-
quine pressure. 
7. 	A discussion of the selection experiments, crossing experiments 
and competition studies is included and further research 
suggested by this work is considered. 
1. 	Introduction 
History of man is made of several descriptions of war, with 
different civilizations having in common the ambition of spreading 
their frontiers and cultures, and dominating larger areas of land. 
Such processes are always costly to both sides, despite, no doubt, 
some advantages in the short term, to the winner. 	In peace time, 
countries have tried to develop and improve living conditions so that 
disease, morbidity and mortality can be reduced in the population. 
However, it was only in 1948 that the United Nations presented a co-
operative programme in which countries from developed and under -
developed areas could prevent, by Public Health schemes, infections 
from spreading as epidemics, these programmes being administered by 
the newly created World Health Organization. 
As malaria was one of the most devastating illnesses of all times 
(Livingstone, 1971) its eradication was planned making use of insect-
icides against the mosquito vector and antimalarial drugs against the 
parasite. 	Antimalarial campaigns met success in countries such as 
Sri Lanka (formerly Ceylon), Mauritius and Cyprus and to a lesser 
extent in India. 	But, counterbalancing the improvement of Public 
Health in many countries, two major problems appeared: the development 
of drug resistant malaria parasites in some areas of South America and 
South East Asia, and the beginning of the Vietnam War which affected 
several countries from different continents, involving increased move- 
ments of. human populations. 	Reports on the emergence of parasites 
resistant to drug treatment encouraged the production of new drugs and 
research on the origin and mechanisms of resistance. 	It is important 
to mention here that intelligent use of any drug, either for treatment 
1. 
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or prophylactic measures is not always feasible, since many areas 
are occupied by migratory populations and the Health Services in 
developing countries may be poorly equipped and staffed. The effect 
of malaria on American soldiers in Vietnam, in which the number of 
soldiers evacuated from action due to malaria was as high as due to 
wounds (Tigert, 1966), stimulated research on malaria therapy as well 
as resistance to malaria drugs mainly related to chloroquine, a drug 
widely used and wrongly conceived as incapable of causing resistance 
(Schmidt, 1969). 	Chloroquiné was used as a substitute for quinine 
since quinine synthesis was uneconomical (Davey, 1951) and the world 
natural supply of quinine was lost to the Allies during the Second 
World War. The approach which has been taken in this work is best 
summarized by a quotation from Sir Charles Harington, who, in 1957, 
concisely remarked that ... "however hard and successfully we may 
work in the search for new drugs we shall therefore continue to labour 
under discouragement so long as we are faced with the bug bear of drug 
resistance. The problem is one of microbial biochemistry, physiology 
and genetics and can only be solved by work in these fields". 
The purpose of this project is to investigate the genetic factors 
involved in chioroquine resistance in malaria. Drug resistance can 
be determined by chromosomal changes and cytoplasmic factors. 	In 
bacteria, some drug resistance is associated with episomes or R factors 
which are cytoplasmic (Watanahe, 1963; Watanabe and Fukasawa, 1966). 
Some classes of erythromycin-resistance have been found to be deter-
mined by cytoplasmic genetic factors located in the mitochondria in 
Paramecium aurelia (Beale, 1969). 	The development of genetically 
Plasmodium 
stable pyrimethamine-resistant mutants of / chabaudi (Walliker et al., 
1975) as well as stable metachioridine resistance induced in P. 
gallinaceum (Bishop, 1958b) suggested chromosomal changes (Walliker, 
1976). Drug resistance of Protozoa has been extensively reviewed 
by Bishop (1958a) and SchnItzer (1963) with the description of methods 
used with trypanosomes and malaria parasites and the results obtained. 
Information on the origin of such resistance and the location of the 
altered genes, if any, can only be carried out by analysing the progeny 
of resistant parasites in the absence of drug pressure, by making use 
of specific chemicals which interfere with plasmids that may carry the 
resistance character, and by crossing resistant parasites with parasites 
of different origins, simultaneously comparing the reciprocal cross 
results. 
In this work the problem of chioroquine resistance has been 
investigated using rodent malaria parasites both because of genetic 
work which has already been carried out using these forms and because 
they represent a convenient model for comparative studies with human 
malaria. 
1.1 Concept of drug resistance. 
Tolerance resulting from prolonged use of a drug is historically 
exemplified by the story of Mithridatès (B.C.) a king who, in order to 
protect himself from the effects of poisons had a lifelong habit of 
taking such substances prophylactically, which rendered him unable to 
take his life by poison when defeated in battle, (Bishop, 1958a) 
Early studies on resistance to drugs in micro-organisms were made 
using bacteria, trypanosomes and malaria parasites. 	In 1910, Ehrlich 
predicted that trypanosomes would develop resistance to any type of 
3. 
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drug designed to attack them, thus suggesting that organisms may 
possess mechanisms which permit them to survive under normally lethal 
conditions. 
When resistance to chioroquine and to other drugs arose in 
malaria parasites, it became necessary to define drug resistance in a 
precise way, in order that similar tests could distinguish different 
types or levels of resistance in different areas. 	The W.H.O. (Geneva, 
1973), defines resistance as a "drug-parasite interaction in which 
there is the. ability of a parasite strain to survive and/or multiply 
despite the administration and absorption of a drug given in doses 
equal or higher than those usually recommended but within the limits 
of tolerance of the subject". 	In general terms, it is a temporary or 
permanent loss of the initial sensitivity of the micro-organism to the 
effect of the active substance. This loss of sensitivity should not 
be confused with the absence or inadequacy of drug action due to de-
fIcient absorption by the host, unusual rate of degradation or excre-
tion of the drug or failure of the host to take the drug, which are 
host factors which may complicate the recognition of resistance. 
1.2 Chloroquine resistance in human malaria 
The first reports confirming that normal doses of chloroquine 
had failed to cure an infection with P. falciparum came from Colombia 
in 1961 (Moore and Lanier; Young and Moore) although in 1960, in 
Venezuela, Maberti had already expressed suspicion on the effectiveness 
of treatment with chloroquine in another human malaria infection 
(cited by Peters, 1970). However, publications long before 1961 
warned against the possibility of resistance. 	Most et al. (1946) and 
Earle and Berliner (1948) cautioned against the use of doses which were 
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effective for P. vivax being administered against P. falciparum strains 
which might not have been so sensitive to the drug. 	Resistance of 
malaria parasites to chioroquine did not apper for more than a decade 
after its inception for antimalarial therapy. 	Resistance to this 
drug was thus slow to emerge, when compared to other drugs such as 
proguanil, to which resistance was detected four years after its 
initial use, and pyrimethamine, to which resistance was reported after 
only two years (Peters, 1970). 	From 1961, a large number of cases of 
malaria resistant to chloroquine were recorded. 	After. further South 
American reports (Moore and Lanier, 1961, from Colombia; da Silva et 
al. 1961; Rodrigues, 1961, from Brazil; Godoy et al., 1975, from 
Venezuela) a number of instances of lack of response of P. falciparuxn 
to treatment with chloroquine in South East Asia were reported 
(Harisanuta, 1962; Montgomery and Eyles, 1963; Eyles etal., 1963; 
Powell et al., 1964; Sandoshan et al., 1966 and Ebisawa and Fukuyama, 
1975). 	Several claims have been made for the existence of chioroquine 
resistance in Africa, but many of these reports have subsequently been 
shown to be false (Jeffery and Gibson, 1966) due to the inadequacy of 
the tests carried out and the results reported (Stevenson, 1966; Lasch 
eta.1., 1965; Bruce-Chwatt, 1974). 	More recently, a careful study 
on chloroquine tolerance by Dennis et al. (1974) on a strain from 
Ethiopia and a case reported by Pillay and Bhoola (1975) on a P. falci-
parum strain not responding to the drug, in South East Africa, give 
circumstantial evidence on the possible existence of resistance to the 
drug in Africa. 
It is of interest that of the four species of human malaria 
parasites, resistance to treatment with chioroquine concerns only-P. 
falciparum. This may be partly due to the greater number of studies 
on this species because of its pathogenic importance, but it is also 
possible that specific characteristics may be involved in the develop-
ment of chioroquine resistance. 
1.3 Chioroquine resistance in laboratory malaria parasites 
The first report of chloroquine-resistance in a laboratory 
malaria parasite was in 1956 when Ray nd Sharrna reported lack of 
response to chloroquine in the avian species P. gallinaceu!n. Following 
treatment with a low initial drug dose and prolonged passaging under 
drug pressure, the parasites became twice as resistant as the initial 
parental strain. 	In 1957, Ramakrishnam etal., using a similar tech- 
nique with P. berghei induced drug-resistance of 200 fold magnitude, 
after 33 blood passages. 	Before t)iese two reports, other research had 
been carried out with the intention of producing chloroquine resistance 
species 
in various malariaA although unsucessful1y. 	These projects included 
research on avian malaria parasites such as P. lophurae (Thompson et al., 
1948), P. gallinaceum (Seaton, 1951; Bishop and McConnachie, 1952) 
and later in P. relictum (Kollert, 1963). 	Simian malaria parasites 
were also used, including P. knowlesi and P. coatheyi (mentioned in WHO 
report, 1967). 
Numerous studies have now been made on chloroquine-resistance in 
rodent malaria species. 	The situation appears to be complicated, as 
there is a natural variation in resistance to the drug among isolates 
resistance 
of the various species, and examples of both stable and unstableJhave 
- 	 been reported. Studies carried out on each of the four species can 
be summarized as follows: 
(1) P. yoelii - All isolates of this species so far examined exhibit 
an innate resistance to chioroquine. This is found in newly isolated 
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parasite lines which have not previously encountered the drug 
(Warhurst and Killick-Kendrick, 1967; Peters, 1968; Carter, 1972). 
(2) P. bérghei - Isolates of this species are naturally chioroquine-
sensitive but resistance has been produced by several authors and the 
techniques employed varied significantly. 	Ramakrishnam et al. (1957), 
Kollert (1963), Peters (1965) and Jacobs (1965) employed similar 
techniques, using low drug doses and frequent blood passaging of 
parasites surviving drug pressure for the selection of resistant 
lines. 	High doses of chloroquine were used by Sautet et al. (1959) 
and Benazet (1965) in a relapse method in which passaging was carried 
out. about ten days after , infection of mice. 	Hawking and Gamrnage 
(1962) induced resistance in P. berghei by blockage of the immune 
system of the host and by drug administration in the diet. Although 
successful once, the same method failed when applied to four other 
lines (Warhurst, 1965). A rapid method was attempted by Hawking 
(1966) in which a single high dose of chloroquine was administered 
to mice with high parasitaemias. One and five hours after admin-
istration of 50mg of the drug, the blood of these animals was ino-
culated into uninfected mice and the whole process repeated. 	In 
neither case, however, were resistant parasites 'produced due, probably, 
to the fact that the peak of chloroquine concentration in the plasma 
is only achieved four hours after the administration of drug 
(Macomber et al., 1966). 	A feature of chloroquine resistance in 	P. 
berghei is its instability in the absence of drug-pressure. 	For 
example, Peters (1965) developed a highly resistant strain (RC), but 
the resistance was lost on removal of the drug. Reports of the 
occurence of stable chloroquine resistance in P. berghei (e.g. Peters 
[1 
et al., 1969) may be due to selection of P. yoelii from mixed in-
fections of P. berghei and P. yoelii, the morphology of the blood 
forms of these two species being very similar. 
P. vinckei - Only one successful attempt to produce chloroquine-
xesistance in this species has been reported. 	Powers et al. (1969) 
used a low pressure method to induce resistance in a strain which was 
already resistant to pyrimethamine. 
P. chabaudi - Until the present work no chioroquine-resistance 
has been reported in this species. 	Peters (1970) showed that a line 
of P: chabdudi possessed similar sensitivity to P. berghei. 
1.4 Chioroquine- mode of action and mechanisms of resistance 
Chioroquine acts as a schizonticidal dnig, being active mainly 
against the asexual erythrocytic forms of the parasites. Despite 
numerous studies by several workers, its precise mode of action re-
mains unclear and explanations for resistance to the drug. are largely - 
- 	speculative. 
Several studies, making use of bacterial nucleic acids, have 
demonstrated the interaction of chloroquine with DNA. Hahn et al. 
(1966) reported on the similarity of quinine and chioroquine on the 
formation of complexes with double stranded DNA with consequent block-
age of DNA and RNA synthesis. This work was carried out with 
Bacterium megaterium, and ribosome degradation as well as inhibition 
of protein synthesis are also described. Cohen and Yielding (1965) 
reported on the intercalation of chloroquine with DNA base pairs. 
Stollar and Levine (1963) reported on the inhibition of bacterial 
transformation by chloroquine, which binds to cytosine and guanine, 
and Allison €t al. (1965) described changes of the double stranded DNA 
helix which is stabilized by the drug at low concentrations. 	Re- 
suits from research on bacterial DNA might not be applicable to 
Plasmodia since DNA in Protozoa is attached to proteins such as his-
tones. Bahr and Mikel (1972) with very interesting work on the 
arrangement of DNA in the nucleus of P. berghei, P. chabaudi and P. 
vinckei (rodent malaria parasites) reported on the similarity of 
host and parasite chromatin structure and composition. 	These 
factors, together with the presence of the nuclear membrane at all 
stages of the growing trophozoite, are unfavourable to the hypothesis 
of the nucleus being the main target of chlo.roquine activity. 
From a wide range of information on the effects of chloroquine 
on the malaria parasite it appears that the accumulation of the drug 
within the red blood cells is dependent upon differences between the 
pH of the plasma and the pH within the red blood cell (Roilo, 1969). 
Macomber et al. (1966) suggested that susceptibility to chioroquine 
was due to permeability to the drug and accumulation of a critical 
concentration. 	These studies were carried out with red blood cells 
parasitized with resistant and sensitive P. berghei, the latter con-
centrating twice as much drug. Even greater concentrations of 
chioroquine in red blood cells containing sensitive malaria parasites 
were demonstrated with more accurate techniques by Fitch (1969, 1972), 
who considered that such accumulation was dependent on the existence 
of binding sites in the malaria cell. Bodammer and Bahr (1973) re-
ferred to the existence of a modified area of the red cell, caused by 
the parasite; a site closely attached to the red cell membrane which 
is presumed to be related to the transport of metabolites and which 
is perhaps a main target of antimalarial activity. 
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Reaction of the drug in the cell is associated with a progress-
ivë change in the pH of the digestive vacuoles as the acid radicals. 
of the parasite proteolytic enzymes are buffered by basic chioroqUifle 
ions, and the parasite is unable to digest haemoglobin. 	The lyso- 
somal organelles of mammalian cells which are at acid pH and in which 
the drug is found to be concentrated are considered to be analogous 
to the digestive vacuoles of the malaria parasites (Homewood et al., 
1972). 	Howells et al. (1972) using P. berghei proposed that 
chloroquine induced starvation of the parasite by causing clumping of 
the pigment and autophagosome formation. In vivo and in vitro studies 
proved the necessity of active haemoglobin metabolism and the presence 
of the digestive vacuoles for chioroquine action. 	Sporogonic and 
exoerythrocytic forms of malaria parasites as well as mature mero-
zoites, which contained no pigment or haemoglobin metabolism or 
digestive vacuoles, were unaffected by the drug (Macomber and Sprinz, 
1967). Apart from the amino acid deprivation due to direct change 
on the pH of the malaria cell, chloroquine may also labilize phago-
some membranes with consequent leakage of enzymes resulting in cyto-
plasmic destruction (autolysis) (Peters, 1974). 
Theories concerning the mechanism of resistance to chioroquine 
have been related to physiological alterations detectable in resistant 
strains of P. berghei and P. falciparum. The decrease in chioroquine 
uptake of red blood cells parasitized with resistant malaria parasites 
(Macomber et al., 1966) was suggested to be due to a deficiency of 
drug-binding sites in the parasites (Fitch, 1972). 	A different 
theory was proposed by Howells (1970) who suggested a change to aero-
bic metabolism in the respiratory mechanism of P. beghei resistant to 
11. 
chioroquine. However, this theory has now been questioned because 
of difficulties in the technique used for the detection of functional 
mitochondria and because of host-cell contamination (Howells and 
Maxwell, 1973a, b). 
Thus, the precise way in which chloroquine acts on sensitive 
forms and the mechanism involved in resistance are still unclear. Be-
cause of the various types of resistance seen among the rodent species 
(described above in Section 1.3), it is possible that several mecha-
nisms may be involved. 
1.5 	Genetics of malaria parasites 
Studies on the genetics of malaria are technical]y difficult 
because of the parasite's complex life cycle. 	Furthermore, dramatic 
morphological changes suggest considerable variation in gene expression. 
The number of chromosomes has not yet been determined and little in-
formation is available on the location of genes and on the possible 
existence of genetic material in the cytoplasm. Genetic studies on 
malaria parasites are important for a complete understanding of pheno-
mena such as drug resistance, its origin and dissemination in parasite 
populations. 
Greenberg and Trembley were the first to attempt to cross lines 
of Plasmodia, using two lines of P. gallinaceuxn differing -in their 
response to pyrimethamine and in their ability to produce exo-erythro-
cytic schizonts. 	The first crosses were unsuccessful (Greenberg and 
Trembley, 1954,a; Trembley and Greenberg, 1954) as no evidence of 
hybridisation was found. 	In a later experiment (Greenberg and 
Trembley, 1954,b), indications of recombination between the characters 
distinguishing the parent lines were reported. This interpretation 
12. 
was, however, uncertain since one of the genetic markers (production 
of secondary exo-erythrocytic forms) was known to be unstable. 	In 
1971, Walliker et al. demonstrated genetic recombination in rodent 
malaria parasites using two lines of P. yoelii which differed in their 
response to treatment with pyrimethamine and in the forms of the enzyme 
glucose phosphate isomerase (GPI) . 	A similar experiment was carried 
out with P. chabaudi (Walliker et al., 1975), crosses being made bet-
ween two lines differing by two enzyme markers (6PGD and LDH) as well 
as by sensitivity to pyrimethamine. These experiments showed that 
recombination and segregation of the parental enzyme forms had occured 
before the emergence of parasites in the blood, results which showed 
that the blood forms were haploid. 	Cytological evidence suggested 
that a reduction division occured probably during development of the 
oocyst (Sinden and Canning, 1973). 	More recent studies were carried 
out with lines of P. yoelii differing in the response to treatment with 
pyrimethamine, enzyme forms (GPI) and in the growth pattern of each 
line (virulent or mild course of infection). 	These studies (Walliker 
et al., 1976) showed that variations in virulence were due to genetic 
differences between the two parental lines. 
In 1969, Yoeli et al. reported the possible existence of a gene 
transfer mechanism between malaria parasites called "synpholia" which 
may occur between two parasites developing in the same red blood cell. 
However, confirmation of this process has not, so far, been made. 
The genetic uniformity of the parasite population within lines, 
for the purpose of a cross, as well as the stability of the character-
istics used as genetic markers is of great importance. Carter 1 s 
(1973) identification of enzyme types from different rodent malaria 
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parasites facilitate the use of these laboratory models for genetic 
studies. 	Utilization of a chioroquine resistant line in a cross 
with a sensitive line had not yet been carried out but it was highly 
a 
relevant to use such/marker in order to understand the genetic basis 
of chloroquine resistance. 
1.6 Objective of this project 
The object of this project has been to investigate the origin 
and genetic basis of resistance to chloroquine in the rodent malaria 
species P. chabaudi. 	In the past, few studies on drug resistance 
have been made using this species; for genetic work, however, it is 
of considerable value because of the extensive amount of enzyme vari-
ation found among wild isolates (Carter and Walliker, 1975) which can 
be used for recornbination studies in crosses (Walliker et al., 1975). 
In the first section a description is given of attempts to pro-
duce chloroquine resistant lines of P. chabaudi using a variety of 
drug selection methods. Once a line resistant to chloroquine was 
selccted, studies on the stability of resistance in the absence of 
&ug pressure were carried out. 
The genetic basis of the resistance obtained in one line was 
then investigated in a cross with a sensitive line of different origin, 
the products of the cross being analysed for each of the parental 
markers. 
In the final section, competition studies involving mixtures of 
resistant and sensitive parasites are described in order to investi-
gate the fate of the resistant parasites in a mixed population and in 
the àbsenbe -of drug pressure. Such studies were made on sporozoite-
induced as well as on blood fonn transmitted infections. 
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2. Material and Methods 
2.1 Lines of Plasmodium chabaudi 
2.1.1 Origin of Plasmodium chabaudi 
P. chabaudi was first described by Landau (1965) who isolated 
the parasite from thicket rats (Thamnomys rutilans, Peters,187 8) of 
the Central African Republic. The development and infection pattern 
of the parasite were studied by Landau and Killick-Kendrick (1966), 
Wery (1968) and Landau et al. (1970). 	Bafort (1968) reclassified 
the parasite as a sub-species of P. vinckei, but due to later studies 
on the enzyme forms and morphology of the parasite (Carter and 
Walliker, 1975), the species has been renamed P. chabaudi. 
2.1.2 	Life-cycle 
P. chabaudi is a typical mammalian malaria parasite with a life-
cycle which involves an asexual phase in the mammalian host and a 
sexual phase in the insect vector. 	In the vertebrate host there are 
two cycles of division, one termed exo-erythrocytic schizogony in the 
parenchyma cells of the liver and the second, erythrocytic schizogony, 
in the blood. The infection commences when uninucleate sporozoites 
are injected into the blood stream by female mosquitoes. 	In less 
than an hour, by an unknown process, liver parenchyma cells are in-
vaded and each sporozoite develops by nuclear division into a schizont 
which matures in 52 - 53 hours producing a large number of merozoites, 
which are released into the blood. 
In many mammalian malaria parasites, secondary exo-erythrocytiC 
cycles of development may also originate from these merozoites, al-
though it is not yet known whether such cycles occur in P. chabaudi. 
In the blood, merozoites invade mature erythrocytes, each parasite 
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forming a trophozoite which grows and divides to produce a schizont 
containing, usually, 4 - 8 merozoites which are released by rupture 
of the host cell. Some merozoites reinvade further red blood cells 
and the same cycle is repeated. 	The cycle takes 24 hours, and 
development of schizonts is synchronous, schizogony normally occurring 
around midnight. 	Sexual forms, termed macro- and micro-gametocytes, 
are produced by some merozoites, which usually predominate after the 
peak of the infection (from the tenth day of infection onwards). 
The complete development of garnetocytes takes place in the mos-
quito host in which fertilization between micro- and macro-gametes 
occurs. 	The zygote is termed an ookinete, which penetrates the mid- 
gut wall of the mosquito, to produce an oocyst. 	The first divisions 
of the nucleus of the zygote are thought to be meiotic (Sinden and 
Canning,1973). 	Eventually, nuclear divisions result in the formation 
of several thousand sporozoites which can be seen in the salivary 
glands of the mosquitoes from the 11th day after infection with P. 
chabaudi.. The sporozoite is inoculated into the new host to recom-
mence the life-cycle. 
2.1.3 Definition of terms 
It is essential to describe the terms "isolate", "line" and 
"clone", which will be used frequently. These terms will be taken 
to have the following meanings:- 
(i) Isolate - this refers to a sample of parasites collected 
on a single occasion from a wild rodent or mosquito and 
preserved either by passaging through laboratory animals or 
kept as deep-frozen material. An isolate is not necessarily 
genetically homogeneous and may even contain representatives 
of more than one species. 
6. 
Line - this refers to a collection of parasites which 
have undergone a particular laboratory passage. 	By strict 
definition every laboratory manipulation of parasites 
creates a new line, but usually parasites are described as 
belonging to a line only after a special treatment, such 
as selection for drug resistance. 	All the parasites in a 
"line" have certain characteristics in common but they need 
not be genetically identical. 
Clone - a clone is a group of genetically identical 
organisms derived from a single cell by asexual reproduction. 
Cloning is a procedure of particular importance in genetic 
work with unicellular organisms, and should always be carried 
out, if feasible, prior to determining the characteristics 
of a new isolate, before using an isolate in genetic experi-
ments, and again before classifying' the progeny of a cross. 
Stabilate - this refers to a population of an organism 
preserved in a viable condition on a unique occasion (Lumsden 
and Hardy, 1965) such as liquid nitrogen preservation of a 
P. chabaudi line. 
2.2 Host species used in this prgject (Table 1) 
For the vertebrate host of P. chabaudi mice and white rats were 
used. The rodents were housed in propylene cages using sawdust as 
bedding, fed with animal cake (MacGregor's) and supplied with drinking 
water supplemented with 0.05% PABA (Para-aminobenzoic acid) an essential 
growth requirement for the parasite (Hawking, 1953; Peters, 1970). 
The animal room was maintained at 18 - 22
0
C under natural light con-
ditions. 	For precise drug resistance and selection tests, female 
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C57 Black mice, aged 4 - 5 weeks were used; for routine passaging 
and cloning C57 Black mice and a selection of mice of mixed strains 
were used. 	For cyclical transmission, mosquitoes (Anopheles sthensi) 
were used which were maintained at 25
0C and 90% humidity conditions 
with alternating 12 hour sequences of light and darkness. 	They were 
fed with a 10% solution of glucose in a 0.05% solution of PABA in 
water. 
TABLE 1 List of rodents and insect host species. 
Host Species Source 
Vertebrate: 
Mouse 	(Mus musculus): 
C57 Black, inbred Centre for Laboratory Animals 
Edinburgh 
Mixed strains Department of Genetics Mouse 
House, Edinburgh 
White rat ('Rattus Centre for Laboratory Animals 
norvegicus) Edinburgh. 
Invertebrate: 
Mosquito (Anopheles stephensi) Laboratory colony. 
2.3 Maintenance of 'malaria 'parasites in 'the laborator 
2.3.1 'Blood passage 
Infections were maintained' by passaging parasitized red blood 
cells from infected rodents into uninfected animals by injection of 
infected blood diluted either in citrate saline (0.9% NaCl, 1.5% Na 
serum 
citrate) or in heparinised/Ringer (50% calf serum, 50% mammalian Ringer) 
Inoculation was carried out by intravenous or intraperitoneal routes. 
L8. 
2.3.2 	Cyclical transmission 
Mosqui±o transmission of malaria parasites was based on the 
method described by Landau and Killick-Kendrick (1966). 	Infected 
rodents, in which gametocytes were present, were exposed to mosquitoes 
which had been starved for 24 48 hours. 	The infected rodents were 
exposed to mosquitoes for a varied length of time (1 - 6 hours) de- 
pending on the feeding performance of the mosquitoes. 	Seven to ten 
days later a small number of mosquitoes were dissected in order to 
count the number of oocysts which had developed on each midgut. 
Fifteen and, eventually, seventeen days after the blood meal, when 
sporozoites were present in the salivary glands, an uninfected mouse 
was exposed to the mosquitoes for transmission of the malaria in-
fection. Patent blood infections could be detected after 4 - 8 days. 
2.3.3, Liquid nitrogen preservation (Deep-freezing) 
When parasite lines were not being maintained by animal passage, 
infected blood was stored in sealed capillaried (stabilates) kept in 
liquid nitrogen, using the method of Lumsden et al. (1966). 	Such 
material, inoculated intraperitoneally into a rodent, after any period 
of storage, induced an infection which became patent from 7 - 14 days 
after inoculation. 
2.4 Parasitaemia estimation 
A thin blood smear was prepared, fixed in methanol and stained 
with Giemsa's stain at pH 7.2. 	Blood was not forced out of the tail 
as parasites adhering to blood vessel walls might have distorted the 
proportion of parasitized red blood cells present in the total number 
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Figure 1. 	Typical parasitaemia curve of a P. chabaudi infection. 
Um 
blood cells counted when parasitaemias were low, to 1,.000 for para-
sitaemias higher than 5%. 
2.5 Preparation of standardized inocula of malaria parasites 
Inocula containing known numbers of parasites were required for 
drug resistance tests and for establishing clones by dilution of in-
fected blood. 	Counts of red blood cells of the donor mouse were 
carried out using a Coulter counter, and the parasitaemia was cal- 
culated. 	The number of parasites present in a given volume of blood 
could then be determined. 
2.5.1 Inocula containing 106 parasitized red blood cells 
A donor was anaesthesized with ether and bled from the.brachial 
vessels, the blood being collected with a Pasteur pipette containing 
a drop of heparin. The blood was diluted in serum: Ringer so that 
106 parasites were present in O.lml volume of diluent. 	Inoculation 
- of mice with 0.lml aliquots was carried out not later than an hour 
after bleeding the donor. At all stages diluted blood was kept on 
ice. 
Figure 1 represents a typical parasitaemia of a P. .chabaudi in-
fection in mice inoculated with 10 blood forms. 
2.5.2 Cloning technique 
To establish clones of blood forms of P. chabaudi in mice, a 
dilution technique was employed (Walliker, 1976). 	. 	Dilutions 
were made from a donor mouse in which at least 90% of the infected 
erythrocytes contained single parasites. 	Mice with low parasitaemias, 
early in the infection, were generally most.suitable. 	Thelprocedüre 
for cloning.by dilution was as follows: a 5 ill  sample of blood was 
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collected from the tail of the donor rodent and diluted in 1 ml of 
aserum: Ringer solution. 	Further dilution steps were then made un-- 
til a concentration of 0.5 parasite per 0.1 ml of inoculum was ob-
tained. 0.1 ml inocula were then injected into a group of 30 - 40 
mice. Using this dilution approximately 40% of the animals injected 
became infected, of which approximately' 75% were predicted to contain 
infections derived from single parasites. 
2.6 Source, preparation and administration of drugs 
2.6.1 chioroquine 
Chloroquine was obtained from May & Baker Ltd. (Dagenham, England) 
in the form of "Nivaquin", a solution of chioroquine sulphate (40 mg - 
chioroquine base per ml). For treatment of mice, dilutions of this 
solution were made in distilled water. 	Drug dose was expressed as rng 
of chloroquine per kg of mouse body weight, so that for mice weighing 
10.0 gm, 0.1 ml of drug solution administered 3 mg of chloroquine base 
concentration. The drug was administered orally, by intubation, in 
0.1 - 0.2 ml amounts. 	Drug solutions were kept under refrigerated 
and dark conditions. 
2.6.2 Pyrimethamine 
Pyrimethamine was obtained from the Welicome Research Laboratories 
(England) in the form of a powdered base ("Daraprim"). 	The drug was 
' 	 J 	cQki 
made up as a suspension using a weak solution of acetic acid and a 2% 
oL 	.tk .-1Y1t44 o 'fe- 	.j ("6 
solution of carboxyrnethyl cellulose (ratio 1:5). 	Drug solutions 
were kept under refrigerated conditions and thoroughly shaken on a 
Vortex mixer before administration. The drug was administered orally 
to mice in 0.1 - 0.2 ml amounts. 
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2.7 Enzyme characterization by starch gel electrophoresis 
Electrophoretic variants of the enzyme lactate dehydrogenase 
(LDH) and 6-phosphogluconate dehydrogenase (6PGD) were examined using 
the method of Carter (1973). 	Parasitized blood was collected from two 
mice at the peak of the infection by bleeding from the brachial vessels 
into citrate saline. 	After centrifugation at 1,500g for 5 minutes, 
parasites were released from their host cells by incubation of the 
pelleted blood cells with half their packed volume of a 0.15% saponin 
solution in normal saline at 37
0
C for 20 minutes. The freed parasites 
were then separated from red cell stroma by high speed centrifugation 
(4,000g for 10 minutes) after the addition of Ringer solution, and 
transferred to a glass container stoppered with non-absorbent cotton 
wool for freeze-drying. 	On completion of the freeze-drying process, 
containers were sealed and kept, under vacuum, at -20
0
C. 	For electro- 
phoresis, 2mg of the freeze-dried material was dissolved in 0.02m1 of 
distilled water. 	The gel buffer was O.1M tris-HC1, pH 8.5 for lactate 
dehydrogenase and 0.1M tris-HC1, pH 7.0'for 6-phosphogluconate dehydro-
genase. 
2.8 In vitro culture 
An in vitro culture system, based on Riecknan's technique for P. 
falciparum (Rieckman et al., 1968; Rieckman, 1971) was designed for 
P. chabaudi, as follows: 3 - 4 days prior to the test, 30 - 40 mice were 
injected with a high number of parasites (1-2 x lO parasites). When the 
average.parasitaemia was approximately 2% all mice were bled into a 
conical flask containing heparin, and kept on ice. Bleeding from the 
brachial vessels was carried out in aseptic conditions. 	1 ml aliquots of 
the blood were then placed into screw cap, flat bottomed glass vials 
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(length: 9.0 cm, width: 3.0 cm, thickness: 0.3 cm) each of which 
contained glucose (5 mg) and either no chioroquine (controls) or 
chloroqu-ine added in various quantities (0.2 mg, 0.4 mg, 0.8 mg and 
1.0 mg). 	Each vial contained 200 units of penicillin solution. 
The blood was shaken gently and the vials were placed in a water 
bath at 390 - 41
0C for a period of 6 hours. 	Incubation started at 
about 9 p.m. and blood smears were made from each sample at 10 p.m., 
11 p.m., 12.30 a.m. and 1.30 a.m. 	Vials were slightly shaken before 
smears were taken. 
2.9 Selection of a line of P. chabaudi resistant to chioroquine 
2.9.1 Origin of parasite material and phenotype 
Two lines of . 'chabaudi were used in this work. 	One line, 
denoted P. chabaudi AJ from the isolate AJ (Carter, 1973) was 
characterized by an electrophoretic form of the enzyme 6 phospho-
gluconate dehydrogenase denoted 6 PGD-3, a form of lactate dehydro-
genase denoted LDH-2 and was sensitive to pyrimethamine. The other 
line, denoted P. chabaudi AS from the isolate AS was characterized 
by an electrophoretic form of the enzyme 6-phosphogluconate dehydro- 
genase denoted 6 PGD-2, a form of lactate dehydrogenase denoted LDH-3, 
and was resistant to 4 daily., doses of pyrimethamine at 15mg/kg 
(Walliker et al., 1975).. 
2.9.2 Methods used for selection of chlbroquine resistant mutants 
Two methods were used in attempts to select mutants resistant 
to chloroquine: 
(i) 	High pressure method: 
This method, carried out only with line AJ, consisted of 
infecting mice by inoculation of 106 parasites followed by. 
treatment of the mice with high doses of chloroquine for 
4 consecutive days, starting four days after inoculation 
of parasites. 	Separate tests were carried out using 20 mg, 
40 rng and 60 mg of ähloroquine/kg/day. 	Mice were examined 
for infection for 15 days following completion of drug 
treatment. 	If relapses occurred parasites were passaged 
Into a new set of mice and treatment was repeated to test 
for resistance. 
(ii) 	Continuous low pressure method: 
This method was used for both lines AJ and AS. 	106 para- 
sites were injected intraperitoneally into two groups of 
mice, one group being submitted to a low dose of chloroquine 
administered 3 hours after inoculation and at a similar time 
on subsequent days and the second group being kept undrugged. 
Sub-passages of infected blood were made weekly from the 
mouse exhthiting the highest parasitaemia, except in in-
stances where slow development of the parasite required some 
extension of this period. The course of infection was 
followed by examining blood smears, prepared every 48 hours 
for each mouse, commencing 24 hours after inoculation. The 
the 
nuither of drugging doses was established from/growth of 
parasitaemia in treated mice and drug pressure was gradually 
increased for each passage according to the growth of in-
fection in the preceding passage. 	For transmission of 
malaria parasites through mosquitoes; drug pressure was 
maintained continuously until gametocytes were observed, 
usually on day 11 - 13 after inoculation. 	The infected 
mouse was then exposed to mosquitoes. 
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By counting parasitaemias for each mouse within group a ratio 
R was calculated: 
mean parasitaemia (%) in drugged group 
R= 
	 x 100 
mean parasitaemia (%) in undrugged controls 
This R ratio permitted comparisons to be made between experiments 
carried out at different times during the year. 	Control studies with 
a sensitive line were carried out simultaneously and under identical 
conditions. 
2.9.3 Standard test for chioroquine resistance 
Following the production of chloroquine resistance in P,; chabaudi 
a standard drug test was devised to distinguish between resistant and 
sensitive forms. 	106 blood forms were injected into mice which were 
treated with chloroquine at 3 mg/kg daily for six days, the first 
dose being given 3 hours after injection of parasites. 	On day 4 
after inoculation of parasites, mice were individually reweighed and 
the drug volume given was readjusted to the increase recorded. Blood 
smears were examined on the sixth and eighth days. 	If parasites 
were present the line was defined as "resistant"; if absent, the 
line wastermed "sensitive". 
2.10 Genetic techniques 
2.10.1 Conducting the cross and recovering the products of the 
cross. 
The method adopted was based on the technique of Wallikeretal. 
(1975 - 	modified by MacLeod (pers. corn.). 	Fig. 2 illustrates 
the method used for a genetic cross between two phenotypically dif-
ferent lines of P. chabaudi. 10 blood forms of each line were 
Figure 2. 	Method for genetic cross. 
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injected intraperitoneally into 5 mice each. 	Four to five days 
later a blood count and parasitaemia count were made for each 
group of mice. Equivalent numbers of parasites of each line were 
then mixed and injected intravenously in a splenectomized rat (1.0 
ml inocula) in order to obtain an increase of gametocyte prodpction 
(MacLeod and Brown, 1976). 	Splenectomy was carried out at least 24 
hours before inoculation of parasites. 	Four to five days latei,1 
when a large number of gametocytes were present, the rat was eposed 
to mosquitoes. In these mosquitoes micro- and macro-gametes of each 
line are formed, and self and cross-fertilization occurs, within and 
between linesrespectively. 	Mice infected from these mosquitoes thus 
contained parasites, of recombinant as well as parental types. After 
mosquito transmission, stabilates of infected blood were stored in 
liquid nitrogen. 	Subsequent tests were carried out, using this. 
stored material, on several different occasions. 
2.10.2 Characterization of products of the cross. 	 - 
(i) 	Testing to demonstrate the presence of recombinant forms 
among the products of a cross. 
A standard drug test (page 24) was carried out on the Un-
cloned products of the cross between chioroquine-sensitive 
and resistant lines. 	On the ninth day after inoculation 
all the infected mice were sacrificed and their blood 
analysed for enzyme type. 
The object of this test was to determine whether the enzyme 
types originally associated with the chloroquine_sensitive 
parental parasite line were present among the products of 
the cross surviving the drug treatment. 
Figure 3. 	Competition studies: 	Analysis of a blood form 
induced infection. 	Proportion of 50%: 50% 
resistant to sensitive parasites. 
DAY DAY DAY 
0 3 10 2ndPeak 
Resistant line 	(R) (1) (2) (2) (2) 
Mixture 	(M) (1) (2) (2) (2) 
Sensitive line (S) (1) (2) (2) (2) 
Inoculation of 106  parasites 
Mass tests and establishment of clones 
Cloning and characterization of the cloned products of 
a cross 
Cloning was carried out by dilution, using the method des-
cribed previously (page 20). 
The clones derived from the products of the cross and 
established on several occasions were analysed with respect 
to each parental character for full analysis of the progeny. 
Control studies 
Parasites of each parental line were treated similarly to 
the mixture (Fig. 2) undergoing simultaneous mosquito 
transmission into mice. These mice were used as donors 
for further passages, cloning and drug treatment as controls. 
2.11 Competition studies 
Competition studies between line 411AS (resistant to chioroquine) 
and line 289AS (the chioroquine-sensitive parental line from which 
the line 411FS had derived), were carried out in the absence of drug 
pressure, using both blood-induced and sporozoite-induced infections. 
Both lines were clones and were transmitted through mosquitoes into 
mice, at the beginning of the experiment. 
2.11.1 Blood form-induced infections 
(a) Experiment 1 (Fig. 3) 
1 x 106 blood forms containing a mixture of 50% resistant : 50% 
sensitive parasites were injected intravenously into three mice. 
The parasitaemia in these mice was recorded every 48 - 72 hours for 
35 days. 	On day 3, day 10 (after the first peak of infection) and 
during the 2nd peak of infection (around day 30), the parasites 
infecting one of these mice were tested for resistance. 	For these 
Figure 4. 	Competition studies: Analysis of a blood form 
induced infection. 	Prqportion of 90% : 10% 






Resistant line 	(R) (1) (2) (3) 
Mixture M1 (1) (2) (3) 
Mixture M (1) (2) (3) 
Mixture M3 (1) (2) (3) 
Sensitive line 	(S) (1) (2) (3) 
Inoculation of 106  parasites 
Mass tests 
Mass tests and establishment of clones. 
tests (termed here "mass tests") blood forms of the mixture were in-
jected into a mouse which was used as a donor for a drug resistance 
test (except for day 3, in which no intermediate donor mouse was used). 
For a mass test, a group of 7 mice were inoculated with 106  blood 
forms, five of which were treated with 3 mg of chioroquine for 6 days, 
starting on day of inoculation, the remaining two mice being undrugged 
controls (See Section 2.9.3.) 
	Blood smears for parasitaemia counts 
were taken on day 6 and day 8. 
Clones were established from the mixed infection on the same days 
as the mass tests described above. On each occasion blood forms of 
the mixture were injected into a mouse from which clones were derived 
on the 3rd day of infection (an intermediate donor mouse was not used 
for day 3 experiments). The standard resistance test was applied to 
each clone (page 24). 
(b) 	Experiment 2 (Fig. 4) 
In this experiment, 10 6 blood forms were mixed in different pro-
portions of resistant to sensitive parasites. 	Line M1 was a mixture 
of 90% : 10% resistant to sensitive parasites, line M a mixture of 
50% : 50% resistant to sensitive forms and line M 3 a mixture of 10% 
90% resistant to sensitive parasites. 	For each line groups of three 
mice were injected intravenously with blood forms of a mosquito trans-
mitted infection. 
On day 3 and during the 2nd peak of infection blood forms of 
each mixture were injected into an intermediate mouse which was used 
as a donor for mass tests as well as cloning, carried out as described 
in Experiment 1, above. 
27. 
Figure 5. 	Competition studies: 	Analysis of a sporozoite 
induced infection. 	Proportion of 50% : 50% 




12 2nd Peak 
Resistant line 	(R). (1) (2) (3) 
Mixture 	(M) (1) (2) (3) 
Mixture 	(MM) (1) (2) (3) 
Sensitive line 	(S) (1) (2) (3) 
Sporozoite infection of mouse 
Mass tests 
Mass tests and establishment of clones. 
Figure 6. 	Competition studies: 	Analysis of a sporozoite 
induced infection from a blood-mixture of 
90% : 10% (line M1 ) , 50% : 50% (line M 2 ) and 






Resistant line 	(R) (1) (2) 
Mixture M 1 (1) (2) 
Mixture M2 (1) (2) 
Mixture M3 (1) (2) 
Sensitive 	(S) 	- (1) (2) 
Sporozoite infection of mouse 
Mass tests and establishment of clones. 
no 
Control infections of the parental lines alone, were examined, 
cloned and tested simultaneously. 
2.11.2 	porozoite-induced infections 
Two experiments were carried out using sporozoites as a source 
for infection of mice. 
Experiment 1 (Fig. 5) 
M line was derived from sporozoites from mosquitoes which had 
been permitted to feed on a blood infection of 50% : 50% resistant 
sensitive forms which had undergone gametocyte differentiation. 	MM 
line was obtained by mixing mosquitoes of control lines in equal pro-
portions, according to the number of oocysts which had developed per 
gut, per parental line. 	In this experiment therefore, the mixture 
ofparasites occured only at the sporozoite stage. 
Experiment 2 (Fig. 6) 
Further experiments were devised in which mosquitoes were in-
fected by feeding on mice which had been injected with the 90% : 10%, 
50% : 50% and the 10% : 90% proportions of resistant to sensitive 
parasites. 
Observations on the course of these infections were made only 
at day 8 after transmission of infection through mosquitoes, for all 
lines R, M1, 142, M3 and S, and at day 12 and day 35 (2nd peak of 
infection) for lines R, M and S of the first experiment. Line MM 




Selection of £. chabaudi lines resistant to chioroquine 
1.3.1 Attempts to produce chloroguine-resistance in line AS. 
A chioroquine resistant line was derived from line AS using the 
continuous low drug pressure method. 	Table 1 illustrates the develop- 
ment of this line from the start of drug treatment (passage 1) until 
resistance was established (passage 6). 	The full history of the pro- 
duction of a resistant line is given in Diagram 1.3.1 in Appendix. 
For the first two passages a drug dose of 2 'mg/of chlorocjuine was ad- 
I 
ministered for 5 days. 	On passage 3 (mice 314AS in Diag. 1.3.1 in 
Appendix) an increase to 3 mg of chloroquine for 5 days eliminated all 
parasites. The blood of these mice was examined until day 10 when 
four mice out of five exhibited a relapse infection. 	These parasites 
were injected into further mice (327AS) and submitted to 3 mg of 
chioroquine for five days, for the next two blood passages 4 and 5 
(327AS and 333AS). 	In these mice the sensitivity to drug treatment 
was significantly lower than that of the sensitive parent line tested 
under identical conditions. 
Although in mice 333AS growth rate was low (R = 2.4), parasites in 
subsequent mice, passage 6 (356A5), exhibited a higher level of resist-
ance. The infection was then transmitted through mosquitoes, drug 
pressure being maintained in mice 356AS until day 11 when mosquitoes 
were permitted to feed. 
Parasites transmitted through mosquitoes into mice (390A5) and 
subsequently tested for resistance using the standard resistance test 
showed a lack of response to this treatment (411AS), while the sensitive 
parent line was eradicated when tested simultaneously. 













1 2 5 607 
2 2 5 28.40 
• 	 3 3 5 0.0 
• 	4 3 - 	 5.. 15.2 0.6 
5 3 5 2.4 0.5 
6 3 continuous 28.05(2) 0.0 
7 Mosquitoes 
8. 0 
10 3 6 21.82 0.0 
R ratio (page 24) 
Resistance established 
Resistance established through mosquitoes (mice 411AS) 
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From passage 10 to 17 (411AS to 514As) (Diag. 1.3.1) weekly blood 
passages were carried out and the dose of chioroquine administered 
was increased up to 6 mg. These passages were carried out as des-
cribed above, except that on day 5 after inoculation (after 4 daily 
doses of 3 mg of chioroquine) a single dose of 6 mg of chioroquine 
was administered. The surviving parasites were now submitted to 3 
mg of chloroquine again on day 6 before being passages into new mice, 
on day 7. 	During the 7 passages the level of resistance was raised 
to the desired level of 6 mg of chioroquine, but this increase in re- 
sistance proved unstable, when drug pressure was relaxed. 	However, 
the parasite line still maintained its resistance to 3 mg (R = 36.3 
for mice number 514AS). 
the 
Control studies showed that this dose eliminated/sensitive line 
AS parasites using the standard drug test. 	It can be seen in Table 	1 
and Diagram 1.3.1 that in passages 4 and 5 there appeared to be a • 
slight increase in resistance in the control sensitive lines but in 
these passages mice were not re-weighed during drug treatment. 	In 
all.subsequent tests, when the drug dose was adjusted on day 4 to take 
account of any increase in mouse weight, parasites were eliminated. 
P. chabaudi line 411AS was thus established as the resistant 
line for further studies. 
1.3.1 (a) Cyclical transmission of chloroqine resistant lines. 
Table 2 represents the cyclical transmissions carried out.on 
several different occasions following the establishment of line 411AS. 
a 
All the lines transmitted were maintained under/continuous drug 
pressure of 3mg/kg daily until the day of exposure to mosquitoes. 
No further chloroquine pressure was used until the first passage 
after each sporozoite transmitted infection. 
Table 2. Cyclical transmission of P. chabaudi AS, resistant to chioroquine, under drug pressure. 
411 AS 
Exp.. Parasitaemia R Ratio % Parasitaemia Day of ex- 1st test after R 
Number 
(1) D1 mean % of for of mouse ex- posure to mosquito trans- Ratio Other 
drugged mice Day 6 posed to mos- mosquitoes mission. Parasit- for information 
on day 6. quitoes,Day 6. aemia, mean % of day 6 
drugged mice on 
Day6 
543 AS 2.7. 3.8 22.0 3.2 D 13 1.97 8.9 sporozoites in- 
1974 D 13 5.0 17.lJ fected intravenously 
D 13 3.06 10, 0 1 sporozoite induced 
5 infection (feed) 
605 AS 11.10 4.65 33.1 6.8 D 11 1.47 9.8 sporozoite induced 
1974 . infection 	(feed) 
606 AS 11.10 3.8. 26.0 5 D 11 1.04 23.91 sporozoite induced 
1974 infection (feed) 
634 AS 17.10 3.16 37.06 (2) D 12 0.4 13.0 On D7 sp1enectomize 
1974 . mice were in- 
fected with 
657 AS 11.12 7.47 59.1 (2) D 13 1.47 70 On D8 parasite blood 
1974 forms from all 
treated mice. 
764 AS 21.5 6.7 32.0 (2) D 12 2.99 	. 14.9 Sporozoite induced 
1975 . infection 15 days 




(1) D1 - day of inoculation and 1st drug dose 	(2) Splenectomised rats used - parasitaemla not estimatea. 
(..J 
Figure 7 
Stability studies on resistance. 
590AS (P. chabaudi AS, resistant) 
+ 
10 passages (No drug pressure) 
+ 
Mouse 	- 	R* = 6.25 
+ 
5 mouse passages (No drug pressure) 
Mosquitoes 	 8 mouse passages - 2 mouse passages 
+ 	 (No drug pressure) (No drug pressure) 
+ 	 + 
Mouse 	 Mouse Mouse 
R*= 8.08 	 R*= 10.39 	 R*= 74 
Control studies 
879AS (. chabaudi AS, sensitive) 
+ 
7 blood passages -3- mouse -3- R* = 0.0 
(No drug pressure) 
8 blood passages -- mouse -3- R* = 0.0 
(No drug pressure) 
* R ratio (see Section 2.9.2 
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Each experiment showed that resistance to chioroquine had been 
maintained through the invertebrate phase of the life cycle. 	In 
experiment 543AS, one infected mouse was exposed to mosquitoes; two 
weeks later the sporozoite transmission was made either by intravenous 
injection of sporozoites prepared from dissected salivary glands or by 
allowing the infected mosquitoes to feed on a mouse. 	In experiment 
634AS and 657AS, parasites were passaged into a splenectomized rat 
prior to mosquito transmission, to produce larger numbers of gameto- 
cytes. 	In experiment 764AS, two mice were separately exposed to in- 
fected mosquitoes, with a 48 hour interval between feeds. 	In all tests, 
as well as in results obtained in subsequent competition studies (see 
Results.ifl Section 111.3.2) chloroquine resistance was maintained 
through mosquitoes. 	This was necessary in the establishment of re- 
sistant lines for the purpose of a cross. 
1.3.1 (b) 	Stability studies on chioroquine resistance. 
To investigate whether parasites which survived chloroquine treat-
ment possessed a stable resistance to the drug, studies on the stability 
of resistance were carried out by continuous blood passaging of re-
sistant parasites in the absence of drug pressure. 
Figure 7 represents the number of passages carried out and the 
results of subsequent tests for resistance. 	During 25 continuous 
blood passages ( 170 generations), parasites were sub-inoculated into 
mice at passage 10, passage 23 and passage 25 and tested for resistance. 
At passage 15, parasites were transmitted through mosquitoes into mice, 
and then tested for resistance. 	 - 
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These studies were carried out for 25 weeks, the parasites being 
passaged on day 7 or day 8 after inoculation. 
In order to study the influence of continuous blood passaging on 
resistance, in the absence of an invertebrate cycle, the parental 
sensitive P. chabaudi AS from which the resistant line had been 
an 
selected was submitted tojiclentical routine and tested after 7 and 15 
passages. 	Both tests confirmed sensitivity of the parental control 
and, thus, no effect of blood passaging on acquisition of resistance. 
For all tests carried out, resistance of line 411AS was thus proved 
stable and transmissible through mosquitoes in the absence of drug 
pressure. 
1.3.2 Attempts to produce chioroquine resistance in line AJ. 
The chloroquine resistant line 411AS was developed from a parent 
line which was resistant to pyriinethamine (page 22, Section 2.9.1). 
The purpose of this study was to produce also a line resistant to 
chloroquine, from a pyrimethainine-sensitive parent line. 	For this 
purpose, P. chabaudi AJ was used. 
Two methods were used in these experiments: 
(i) 	High pressure method: 
Fifty mice infected with line AJ were treated with doses of 20 
ing of chioroquinè for four days. Fourteen days after the first drug 
dose, relapse parasites appeared in seven mice which were passaged and 
tested for resistance by treatment with 20 mg of chioroquine under 
identical conditions. No evidence of resistance to the drug was ob-
tained as parasites were eradicated after the last drug dose. Studies 
were discontinued at this point. 
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Doses of 40 mg of chioroquine administered for four days to 10 
infected mice eliminated the parasites for 12 days, after which 3 mice 
exhibited low parasitaemias (0.7%, 0.3% and 0.4%). 	These lines were 
passaged and tested, separately, using the same drug dose, which elim-
inated all the parasites, studies being discontinued at this point. 
Doses of 60 mg of chloroquine administered to 10 infected mice 
eliminated all parasites and no relapses were detected for 28 days after 
the first drug dose. 
(ii) 	continuous low pressure method: 
Full history of the results obtained is summarized in Table 3, 
and is given in Diagram 1.3.2, in the Appendix. 
Line AJ was first passaged through groups of mice (passages 1 
and 2) in which drug doses of 3 mg/kg of chioroquine were administered 
for 
40  and 3 days respectively. The dose was lowered to 1.5 mg (con-
tinuous exposure) for passage 3. Ten days later, parasites surviving 
this drug pressure were passaged into mice which were treated with 3 ing 
of chloroquine for 6 consecutive days without elimination of the parasites. 
The repetition of this treatment in passage 5, confirmed resistance of 
P. chabaudi AJ to this dose of chioroquine, (mice 524AJ). 	Clones were 
established from line 524AJ and drug tests confirmed resistance to 
chloroquine. 
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1 3 4 0.0 
2 3 3 1.72 0.0 
3 1.5 continuous 29.8 - 
4 3 6 4.8 0.0 
5 3 6 7.76 0.0 
R ratios (page 24) 
Resistance established (mice 524 AJ) 
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1.3.2 	(a) Cyclical transmission of chioroquine resistant. lines. 
Parasites derived from 524AJ and from clones established later 
were transmitted through mosquitoes and then tested for chioroquine 
resistance using the standard drug test. 	The two clones, resistant 
to the drug under serial blood passaging and drug pressure, were 
drug sensitive after mosquito transmission. However, when the para-
site population from which these clones were, derived had been cycli-
cally transmitted resistance was still present after mosquito trans-
mission. 
These results suggested the existence of different types of re-
sistance in the selected chioroquine resistant line 524AJ, the cloned 
lines established being unsuitable for a cross as chloroquine re-
sistance was not transmissible through mosquitoes. 
These results are shown in Table 4, and fully represented in 
Diagram 1.3.2 (a), (b) and (c) in the Appendix. 
1.3.3 	vitro culture results 
In vitro culture of P. chabaudi was carried out with lines 411AS 
(resistant to chioroquine), 290AS (the chioroquine sensitive parental 
line from which 411AS had derived) and 468AJ (a line sensitive to 
chloroquine). 	It was found that line 411AS developed schizonts and 
merozoites 1 - 2 hours earlier than the other lines. Reinvasion of 
uninfected red blood cells by merozoites was also detected, but as the 
culture would not last longer than 6 hours a continuous observation on 
the development of schizonts was not feasible. 
Blood smears from in vivo controls confirmed earlier schizogony 
in the resistant line 411AS. 
ME 
Inconclusive results were obtained on attempting to classify the 
levels of sensitivity of the different lines, due to technical dif 
ficulties which are discussed later (page 68). 
TableA Cyclical transmission of 524AJ and 2 clones established 
from this resistant parasite population. 
Standard test 1 	 Standard testW 
524AJ 	31.6 	 Mosquitoes 	8.4(2) 
clone 1 	6.9 	 Mosquitoes 
clone 2 	7.9 	 Mosquitoes 	
0•0(3) 
Mosquitoes 	 Clone 1 	Clone 2 
.1' 





Maintenance of resistance through mosquitoes 
Loss of resistance through mosquitoes. 
Fl 
Figure 8. Phenotype of chioroquine resistant and sensitive_ 
lines, used in cross. 
Lines Phenotype 
411AS Resistant to 3 mg chioroquine 
(6 daily doses) 
Resistant to 15 mg pyri- 
methamine 	(4 daily doses) 
6 PGD-2 
LDH-3 
96A3 Sensitive to 3 mg chioroquine 
(6 daily doses) 
Sensitive to 15 mg pyri- 






411AS 8 blood passages from 	+ 657AS 	663AS* 	-- Mosquitoes 	+ Mice 680AS (deep-frozen) Ct 
25/9/74 to 4/12/74 under (R=59,1\ 
drug pressure. \ 
283PSJ** Mosquitoes 	Mice 329ASJ (deep frozen) 
C) 
96AJ 8 blood passages from 	+ 707AJ I 712AJ* + Mosquitoes 	Mice 722AJ (deep frozen) 
25/9/74 to 4/12/74 (R=O.0) 
* Blood passage of parasites through splenectomized rats 
** Deep frozen stabilates made. 
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SECFICN II 
Cross between 411AS and 96AJ 
11.3.1 History of parental lines 
After the production of the stable and transmissible chioroquine 
resIstant line 411AS, genetic studies were carried out in order to in-
vestigate the genetic basis of the resistance produced and whether it 
showed recombination with other genetic markers. 	A cross was made bet- 
ween line 411AS and a line of different origin, 96AJ, which differed in 
4 markers as shown in Figure 8. 
11.3.1 (a) 	Analysis of products of cross. 
In Figure 9 a summary of the genetic experiments carried out is 
shown. Deep-frozen stabilates were prepared of the products of the 
cross (mice 329ASJ) and the parental lines (mice 680AS and 722AJ). 
(i) 	Tests for genetic recombination: 
Capillaries taken from stabilates of each parental line and the 
products of the cross were removed from the deep-freeze and injected 
into separate groups of mice. 	106  blood forms from each line were in- 
jected into three groups of mice, one group being undrugged, the second 
group submitted to treatment with 3 mg of chloroquine and the 3rd group 
submitted to 15 mg of pyrimethamine. Following drug treatment, para-
sites in each group were examined for enzyme-type (6 PGD and LDH). If 
no recombination had occured, drug-treatment in each group would be ex-
pected to eliminate all the drug-sensitive PJ type of parasites, only 
the drug-resistant AS parasite forms remaining (6 PGD-2 and LDH-3). 
Thus, if after drug treatment both forms of each enzyme were present in 
the surviving population, it could be concluded that new parasite forms 
had been produced by genetic recombination following the cross. 
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The untreated products of the cross would be expected to show 
all enzyme forms, but these might represent both parental forms as 	- 
a simple mixed infection. 
Table 5 represents the results obtained by drug testing the 
parasites derived from the cross between 411AS and 96AJ and shows 
that both enzyme forms of the parental sensitive line AJ are present 
after treatment of mice infected with the products of the cross. It 
could be concluded, therefore, that genetic recombination between 
drug-markers and enzyme-markers of the parental lines had occured. 
Similar results were obtained using stabilates from mice infected 
separately from the same group of mosquitoes. 
(ii) 	Characters of clones derived from products of cross. 
70 clones.were established by dilution of blood forms of the 
products of the cross. Each clone was tested for enzyme-type and 
drug-response by injecting 106  parasites into three groups of mice 
each, as described in the previous section. Table 6 shows the 
characterization of the 70 clones obtained. Groups A - Q in Table 
6 represent the 16 possible classes of character combinations. Groups 
• 	A and Q represent line A3- and AS-character classes respectively, and 
groups B - P are recombinant classes. It can be seen that despite 
the absence of clones in five groups (C, D, G, H and P), recombination 
occured between each of the parent-line markers. 
32 of the seventy clones were chloroquine resistant, the R ratios 
for each of them being shown in Table 11.3.1 in the Appendix. 
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11.3.2 Control studies 
As controls, parasites of the 2 parental lines (mice 680AS and 
722AJ) were cloned by dilution of infected blood after mosquito trans-
mission of each line. 	Of 60 mice inoculated, for control 680AS, 24 
clones were obtained and individually tested, the phenotype being for 
each clone, LDH-3, 6 PGD-2, pyrimethainine-resistant and chioroquine- 
resistant. 	The R ratios of each clone are given in Table 11.3.2 in 
the Appendix. 
Of 60 mice inoculated, for control 722AJ, 14 clones were obtained 
and individually tested, the phenotype being for each clone LDH-2, 6 
PGD-3, pyrimethamine-sensitive and chioroquine-sensitive. 
These results suggested, therefore, that mutation events were 
unlikely to have accounted for the recombinant types of parasites among 
the products of the cross. 
Table 5. Results of drug tests of products of the cross and parent 
lines controls 
Lines 680 AS 329 ASJ 722 AJ 
Drug- UND 3mc l5m UND 3mg 15mg UND 	3mg 	15m9 
Test cq. 	2) Pyr. cq. Pyr. cq. Pyr.. 
10.4 0.35 0.25 12.2 0.47 0.08 11.9 	(-) 	(-) (1) 	. 
LDH 
forms 3 3 3 2/3 2/3 2/3 2 
6PGD 
forms 2 2 2 •2/3 2/3 •2/3 3 
Figures represent mean parasitaemias (% of red blood cells 
infected) on day 6. 
cq =.chloroquine 	 - 
• (3) Pyr. = Pyrimetharnine 
tJJP 
Table 6. Characterization of 70 clones established from the 












A 2 3 S S 32 
B 2 3 .S R 11 
C 2 3 R S 0 
D 2 3 .R R 0 
E 2 2 S S 2 
F 2 2 S R 7 
G 2 2 R S 0 
H 2 2 R R 0 
I 3 3 S S 1 
J 3 3 S R 2 
L 3 3 R 5 2 
M 3 3 R R 1 
N 3 2 S 5 1 
0 3 .2 S R 7 
P 3 2 R S 0 
Q 3 . 2 R R 4 
Totalnumber of clones- ............................. 70. 
R - resistant to drug pressure 
S - sensitive to drug pressure 
LDH-2 or -3 : electrophoretic forms of the enzyme lactate dehydrogenase 




11.3.3 cyclical transmission and stability studies ona 
recombinant resistant clone. 
It was shown in Section 1.3.2 that cloned parasites resistant to 
chloroquine, derived from line AJ (pyrimethamine sensitive, LDH-2, 6 
PGD-3) did not maintain their resistance after transmission through 
mosquitoes. 	From the cross carried out between lines 411AS and 96AJ, 
11 clones were found in group B which possessed the enzyme forms 
characteristic of AJ, were sensitive to pyrimethamine and were resist- 
ant to chloroquine. 	Further studies on one of these clones (347ASJ) 
were carried out as follows: 
Cyclical transmission and tests for resistance of the 
mosquito transmitted parasites. 
Line 347ASJ was tested for resistance before transmission through 
mosquitoes, using the standard drug-test. The R ratio for day 6 was 
9.0. The line was then transmitted through mosquitoes into two mice. 
One mouse was infected with sporozoites from mosquitoes fifteen days 
• after their "feed" on gaxnetocyte carriers and the second with sporozoites 
after twenty days. After drug-testing the R ratios were R = 6.4 and 
R = 3.0, respectively. 
Stability studies 
347ASJ was continuously transmitted in the absence of drug pressure 
through mice for 19 weekly passages (made on day 7 or 8) and tests for 
resistance were carried out at passage 10 and passage 19, the R ratios 
being respectively R = 18.1 and R 13.2. The resistance acquired by 
recombination during the cross was thus stable in the absence of the 
drug. 
These results show therefore that, by genetic recombination, stable 
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chloroquine resistant lines were produced which possessed enzyme 
characteristics of line AJ and which were pyrimethamine sensitive. 
Previously, it had proved impossible to develop such lines by simple 
chioroquine selection on line AJ alone (Section 1.3.2(a)). 
III Competition studies 
The object of these studies was to investigate the fate of 
chloroquine resistant mutants in mixed populations in the absence of 
drug-pressure. 	The stable chioroquine resistant line 411AS was mixed 
in different proportions with the sensitive line from which it had 
been derived by continuous low pressure. The following results were 
obtained: 
111.3.1 Blood form-induced infections 
(i) 	Results of experiment 1: 50%resistant: 50%sensitivebloodformS 
The mass tests and characteristics of clones established after 3 
and 10 days and at the second peak of infection of this mixture are 
presented in Table 7. The second peak occured 30 days after inoculation 
of lines S and R, and 32 days after inoculation of line M,the peak of 
infection (3.4% red blood cells parasitized) being on day 35. At the 
start of the experiment each line was tested separately for chloroquine 
response the R ratios being R = 0.0 for the sensitive line and R = 12.27 
for the resistant line. The results show that both sensitive and re-
sistant forms are kesent at early stages in the infection, but that 
there was a predominant number bf resistant parasites later, when re-
lapse forms were tested. Thus, at day 3, 9 sensitive to 11 resistant 
clones were found, while at the second peak 0 sensitive to 9 resistant 
forms were found. From these results three conclusions were made: 
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The ratio of 9 resistant to 11 sensitive forms obtained on 
day 3 suggested that the proportion of 50 : 50 resistant 
to sensitive parasites had been correctly established. 
An advantage of the chloroquine resistant forms is seen 
from the 9 : 0 resistant to sensitive clones obtained at 
the second peak of infection. 	At day 10, only two clones 
(both resistant) were established and because of the low 
number, no evidence for such advantage could be concluded. 
Mass tests of line R, at the second peak, showed higher 
levels of R ratios comparatively to day 10. 
(ii) Results of experiment 2: 90% resistant: 10% sensitive blood 
forms (M1),50% resistant: 50% sensitive blood forms (M 2 ) and 
10% resistant: 90% sensitive blood forms (M 3 ). 
The results of these studies are shown in Table 8. 
Relapse infections (2nd peak) occured 30 days after inoculation 
for lines S and M3 and R and 42 days after inoculation for lines M 1 
and M2 . 	The parasitaemias at this stage were .0.41%, 0.16%, 1.07%, 
0.08% and 0.5% for lines R, M, M 2 , M3 and S, respectively. 	The re- 
suits obtained suggested, as in experiment 1(a) predominance of re-
sistant parasites in the population mixtures as the infections proceeded. 
Clones were established only for 2nd peak infections. 	8 resistant to 
o sensitive, 9 resistant to 0 sensitive and 4 resistant to 0 sensitive 
forms were obtained for lines M1 , M2 and 143 respectively. 
At the second peaks, R values for mass-tests were higher than the 
values obtained for each line at day 3. 	- 
The values of R ratios for mass-tests obtained at day 3 did not 
vary accordingly to the proportions of resistant to sensitive parasites 
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inoculated 	(R = 8.30, 13.9 and 0.13 for lines M 1 , 	M2 and 
respectively). 
Individual R ratios of resistant clones tested are given in 
Table 111.3.1 in the Appendix. 
111.3.2 Sporozoite-induced infections 
Sporozoite-induced infections have the advantage over blood 
form-induced infections of resembling more closely the wild situation. 
Line M represents a cross between both lines as the mixture was made 
at the gaxnetocyte stage of infection.. Line MM represents a mixture 
carried out at the sporozoite stage, by mixing mosquitoes, infected 
separately, with sensitive and resistant parasites. 
Results of experiment 1: lines R, M, MM and S 
The results of these studies are shown in Table 9. 
At day 12 only mass-tests were carried out, the R ratios being 
R = 4.5, 2.26, 2.34 and 0.0 for lines R, M, MM and S respectively. 
Second peak infections occured after 35 days for lines R, M and S, and 
60 days after for line MM. Clones established from each of these 
infections showed a preponderance of resistant forms (6 resistant to 
2 sensitive forms for line M and 24 resistant to 0 sensitive forms 
for line MM) and an increase of R ratios obtained at the second peak 
of infection compared to day 12. 
Results 'of 'experiment 2: lines M1 ,M2 'and M3 
These results are shown in Table 10. 
Mass tests were carried out for line R (resistant control) and 
the three diffrent mixed populations at day 8 after sporozoite mo-
culation, the R ratios being R = 23.6, 16.6 and 4.98 for M1 , M 2'and 
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respectively. 	Transmission of line S (sensitive control) was 
unsuccessful. 	From the drug tests carried out with clones established 
for each line the following results were obtained: 0 sensitive to 11 
resistant forms in line M 1 , 0 sensitive to 8 resistant forms in line 
M2 and 2 sensitive to 4 resistant forms in line M3 . 
Individual R ratios of resistant clones tested are given in Table 
111.3.2 in the Appendix. 
All results from the competition studies, carried out in the ab-
sence of drug pressure suggested an advantage of the resistant over 
the sensitive forms in both blood-form and sporozoite-induced infections. 
Table 7. Competition studies: 	results from blood-form induced 
infection of a 50 : 50 proportion of resistant to 
sensitive parasites. 
DAY 3 DAY 10 2nd Peak 
(1) 
Lines: R M S R M S R M 	S 
Mass-test 
(R ratios) -* 1.45 0 2.1 1.1 0 6.9 2.5 	0 
Number of clones 
tested 2 20 6 0 2 6 15 9 	13 
Number of: 
Resistants 2 11 0 0 2 0 15 9 	0 
Sensitives 0 9 6 0 0 6 0 0 	13 
- * - Experiment not carried out. 
(1) R - control resistant 
M - Mixture of 50 : 50 resistant to sensitive forms. 
S - Control sensitive. 
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Table 8. 	Competition studies: results from blood-form induced 
infection. 	90:10, 50:50 and 10:90 resistant to 
sensitive parasites. 
DAY 3 2nd Peak 
Lines: R 	M1 	M2 	M3 	SI1) R M1 M2 M3 	s 
Mass-test 
(R ratios) 9.7 	8.3 	13.9 	0.13 	0 31.7 25.9 21.6 18.1 0 
Number of clones 
tested - 	 - 	 - 	 - 	 -* 8 8 9 4 	-* 
Number of: 
Resistants 8 8 9 4 	- 
Sensitives 0 0 0 0 
* - Experiment not carried out. 
(1) R - Control resistant 
- 90% resistant : 10% sensitive form-mixture 
- 50% resistant : 50% sensitive form-mixture 
M3 - 10% resistant : 90% sensitive form-mixture 
S - Control sensitive. 
so 
Table 9, 	'Competition studies: results from sporozoite induced 
infection, lines M and MM. 
DAY' 12 2nd Peak 
'Lines: R 	M 	MM 	S R M MM S 
Mass-test 
(R ratios) 4.5 	2.26 	2.34 	0 10.9 24.3 15.6 0 
Number of clones (2) 
tested 	 " -' 	 - 	 - 	 - 12 8 24 12 
Number of: 
Resistants 12 6 24 0 
Sensitives 0 2 0 12 
line M - mixed line obtained from a mixture of 50% : 50% 
resistant to sensitive blood-forms injected in a 
mouse and later exposed to mosquitoes. 
line MN- mixed line, obtained from a mixture of 50% : 50% 
resistant to sensitive sporozoites. 
Experiment not carried out. 
Table 10. Competition studies: results from sporozoite induced 
infection of lines M11 M2 and M3 . 
DAY8 
Lines: R 	M1 M2 M3 	S 1 
Mass-tests . 
(2) 
(R ratios) 11.0 	23.6 16.6 4.98 	- 
Number of clones 
(3) 
tested - 	 11 8 6 
Number of: 
Resistants 11 8 4 
Sensitives 0 0 2 
- line M1 : 	90% resistant : 10% sensitive form mixture. 
line M 2 : 	50% resistant : 50% sensitive form mixture. 
line M 3 : 	10% resistant : 90% sensitive form mixture. 
- unsuccessful transmission of line S (control sensitive) 
• through mosquitoes. 	• 




4.1 General considerations on mechanisms of drug-resistance 
The appearance of parasites which survive drug treatment can be 
considered either as mutant forms in the population resistant to the 
drug which are selected by the drug, or as forms which, due to cell 
adaptations, temporarily resist the inhibitory effects of the drug 
under drug pressure. 	In malaria, resistance is of special importance 
when the new forms are able to transmit the character to their progeny, 
through mosquitoes. Any form of adaptation to the drug, which re-
presents a reversible change, is of less importance as it does not mean 
a permanent alteration in the progeny. 
Hinshelwood (1946), in a theory of direct induction, suggested that the 
contact of sensitive bacteria with a drug may shift the normal equili-
brium of cellular chemical reactions to a new equilibrium which is less 
susceptible to the action of the drug. The proportion of cell compon-
ents is altered and cell growth rate in the new conditions is dependent 
on a particular reaction path gradually selected. 	This theory, however, 
does not explain how changes of this type would be maintained in the 
absence of drug pressure, why clones from a resistant population may 
exhibit different degrees of resistance or how mutation to the drug can 
occur in the absence of the drug pressure. The mutation theories pre-
sent two possibilities: either the parasite population exhibits vari-
ation in the response to drug treatment, due to random, spontaneous 
events unrelated to the environment of the organism, or there is a 
direct effect of the drug on the genetic material of the organism, by 
which mutations are induced and depending on their fitness, are main-
tamed in the population. In the case of drug-resistance, highly 
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resistant lines due to mutation may not be produced after a single 
exposure to the drug, but by the gradual accumulation of several 
mutations, with an additive effect, over a number of .  generations. 
Cavalli-Sforza (1957) suggested that different mutations with pre-
sumably different fitness values would account for variance within a 
resistant population. 	Such variance was also explained by Yudkin's 
theory of clonal variation (Yudkin, 1953). 	The basis of the theory 
is that a bacterial cell, of whatever resistance, may give, on division, 
two cells with different and unequal resistance. 	Under drug pressure, 
cells from a cloned line would be selected, gradually, to the develop- 
ment of almost any level of drug resistance in the population. 	But, 
as Pollock (1960) pointed out, drug resistance can depend on the cumu-
lative effects of a number of separate gene mutations; selection 
pressure at a given drug concentration would not necessarily operate 
in favour of a very highly. resistant gene combination when a less 
highly resistant mutant would grow just as well. Also, the theory of 
cional variation does not explain cases of high mutation rates when 
a high levelof resistance is obtained very rapidly. Other reports 
on drug resistan"ce were also difficult to explain satisfactorily using 
these models. 	For instance, in experiments carried out by Hinshelwood 
(cited by Demerec, 1957) on galactose fermentation in yeast, there were 
clear Mendelian phenomena, superimposed on which there were adaptive 
• developments of the segregated characters themselves, the continuous 
• levels obtained being.suggested as dependent on both phenomena acting 
• 	simultaneously. 	 . • • 
• 	The possible modes of origin of drug-resistance in micro-organisms 
are concisely summarized by Bryson and Szybalsky (1955), as follows: 
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Resistance being dependent upon change of genotype, either 
by mutation which can be induced by the drug itself, by 
non-specific mutagenic agents or by genetic exchange pheno-
mena such as sexual recombination. 
Resistance being dependent upon non-genetic change of pheno-
type, either by induction of a new physiological function 
such as an alternative pre-existing pathway, or a variety 
of phenotypic adaptations leading to resistance such as 
alterations in the permeability of the cell to the drug. 
The development of resistance to chioroquine in the P. chabaudi 
lines described in the present work is discussed in relation to these 
theories in the following sections. 
4.2 The nature of 'chioroquine resistance in P. chabaudi 
4.2.1 thloroquine resistance in line AS. 
P. chabaudi (411AS) became resistant to chioroquine after con-
the 
tinuous exposure to low levels of/drug. The resistance was maintained 
through mosquitoes and after continuous blood passaging in the absence 
of drug-pressure. This stability suggests that the resistance probably 
arose by mutation and selection in the presence of the drug. 	It was 
not possible to increase the level of resistance to higher than 3 mg/kg 
of chioroquine. This may be due to the fact that weekly passages of 
the treated parasites for only 7 passages did not allow such mutants 
to be detected. Several generations may elapse between the genetic 
event and its expression. However, parasites exhibiting an unstable 
resistance to higher drug levels were produced, suggesting adaptation 
to these'levels. 	It is possible that mutations to higher levels could 
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a 
have occured had the selection experiments continued for/longer period 
of time. Slower growth of parasites in the presence of drug pressure 
might increase the mutation rate. 
The demonstration that line 4llAS maintained its resistance 
after mosquito transmission has important implications concerning the 
spread of such resistant mutants in wild populations. 
4.2.2 Chloroquine resistance in line AJ 
Results obtained from low and high pressure selection will be 
discussed separately. 
(a) 	Low pressure selection 
The selection experiments using continuous low chloroquine pressure 
on line AJ produced evidence for the development of two forms of re-
sistance to the drug, (i) a stable, heritable form, detectable after 
mosquito transmission and (ii) an unstable form, which could not be 
detected after transmission. 	 - 
Table 4 (page 38) illustrates the results on which this evidence 
is based. After exposure to chloroquine, a parasite line denoted 
524AJ was produced which exhibited resistance to the drug. When this 
parasite population was transmitted through mosquitoes, resistance could 
still be detected. 	Two clones established from 524AJ, before mosquito 
transmission, exhibited chloroquine-resistance, when drug pressure 
was maintained continuously. When the two clones were transmitted 
through mosquitoes, however, each proved sensitive to the drug. 
The simplest explanation for these results is that during the 
chioroquine selection treatment of the' parent sensitive line AJ, two 
different cellular alterations had occured, one being an adaptation'to 
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the drug and the second a mutation event, conferring stable resistance. 
Line 524AJ may thus have comprised a mixed parasite population, some 
or all of the parasites being adapted and some (perhaps only a small 
number) containing the mutant gene. By cloning, only adapted forms 
were isolated, which lost their resistance after cyclical transmission. 
By transmitting the whole population 524AJ, adapted parasites were 
eliminated by subsequent drug treatment, but the mutant parasites were 
able to survive. 
Further work will be necessary to establish whether this ex-
planation is correct: 
A large number of clones could be isolated from line 524AJ and 
tested for drug response, and each clone then transmitted 
through mosquitoes in order to check the stability of resist-
ance. This experiment would establish whether a mixture of 
mutants and adapted parasites was present in the resistant 
population, before mosquito transmission. 
Continuous blood passaging of these clones in the absence of 
drug pressure would also distinguish mutants from adapted 
parasites which would be expected to lose resistance with 
passaging. 
By cloning the resistant population obtained after mosquito 
transmission of 524AJ one would expect the vast majority of 
clones to be resistant, sensitive forms, if any, being due 
to rare.events such as back-mutations, reversion to sensiti-
vi-ty or to other genetic processes such as supressors. 
These resistant forms would also be expected to maintain 
resistance through mosquitoes. 
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(b) 	High pressure selection 
High doses of chloroquine were used and relapse parasites were 
tested with identical drug pressure. No resistant mutants were pro-
duced by these methods, but these experiments were -incomplete. 	In 
further work using these methods, relapse parasites should be tested 
at lower drug doses, to which they might have become resistant. Also, 
in the work reported here, parasites which relapsed after the initial 
drug selection which were tested again using a similar course of 
treatment appeared to be sensitive. However, these experiments were 
discontinued immediately after drug treatment had finished; further 
examination of the second group of treated mice might have revealed 
resistant parasites later. 	Continuous passaging of relapse parasites 
for each line (20 mg and 40 mg) was not carried out for the eventual 
selection of a mutant line as in the method of Sautet et al. (1959) 
and BenaZet (1965) successfully applied to P. berghei. 
From these experiments it was concluded only that 60 rng of 
chioroquine administered for 4 days totally eradicated P; chàbaudi 
infections of mice. 	 - 
4.2.3 Relationship - to pyrimethamine-resistance 
(a) Line AS differed from line AJ in its response to another anti-
malarial drug, pyrimethamine, and in the enzyme forms of LDH and 6 PGD. 
The effect of such differences on the acquisition of resistance to 
chloroquine is unclear. 	Powers etal. (1969)- in attempts to select 
achioroquine resistant mutant in P; vinckei reported that success was 
obtained only by using a strain which was resistant to the maximum 
tolerated dose of pyrimethamine; no chioroquine-resistance developed 
when a pyrimethamine-sensitive strain was used. In human malaria it 
WO 
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seems clear that the occurence of chloroquine-resistance occurs in-
dependently of resistance to antifolate drugs. Thus, although 
chioroquine-resistant strains of P. 'falciparum occuring in South 
America were reported to be frequently resistant to pyrimethamine, 
chioroquine-resistant P. falciparum from Cambodia was usually sensi-
•tive to that drug (Peters, 1970), even though in both continents 
pyrimethamine was widely used for prophylaxis. 	In Africa, pyrimethamine 
was also widely used as a prophylactic and although resistance to that 
drug was reported, no knowledge of chioroquine resistant P. falciparum 
exists (Peters and Seaton, 1971). 	In the rodent malaria parasite, P. 
yoelii, isolates are innately and stably resistant to the drug dose 
of 40 mg of chloroquine/kg but the species is sensitive to pyrimethamine 
treatment (Warhurst and Killick-Kendrick, 1967). 	Similar results are 
reported with different P.; berghei strains resistant to chloroquine 
(Schnitzer, 1966). 
(b) The results of the genetic studies in the present work (to be 
discussed in more detail in Section 4.3) .show'clearly that separate 
genetic factors control resistance to chloroquine and to pyrimethamirie. 
In the cross between lines 411AS and 96AJ, recombinant forms which were 
chloroquine-resistant but pyrimethamine-sensitive were produced. 
Cyclical transmission of one of these clones (line 347ASJ) as 
well as continuous blood passaging in the absence of drug-pressure 
for 19 weeks confirmed the stability of the chioroquine resistance in 
this pyrimethamine sensitive line. 	These studies showed, therefore, 
that parasites resistant to chloroquine but sensitive to pyrimethamine 
can arise by genetic reconibination and suggested their persistence in 
mixed populations, once produced. 
59. 
It is not clear, therefore, why in the present work and in that 
of Powers et al. (1969), the production of stable chioroquine-
resistance by drug pressure on pyrimethamine sensitive lines was less 
successful than when pyrimethamine-resistant lines were used. 
4.3 Genetic Studies 
In order to investigate the mechanism of transfer of chloroquine 
resistance among malaria parasites a cross between the chloroquine-
resistant line 411AS and the sensitive line 96AJ was performed. 	An 
examination of the characteristics of 70 clones derived from the cross 
showed that chioroquine-resistance in P. chabaudi is a stable character 
which can undergo genetic recombination with other markers. Although 
limited by the number of clones analysed, no linkage with the 3 other 
markers used (pyrimethamine-resistance, LDH-3 and 6 PGD-2) was apparent. 
Each of the latter three markers also appeared to be unlinked, results 
which confirmed those of Walliker et al. (1975). 
From a study of the numbers of clones in each of the 16 possible 
classes of progeny, the following observations could also be made: 
(1) Although the total number of clones of parental type characters 
(36) was close to the predicted number (40), assuming random 
fertilization of gametes, there was a disproportionately high 
number of AJ type clones among these, 32 being of type AJ 
(group A) and only 4 of type AS (group Q). The significantly 
different number of parental type forms recovered from the. 
products of the cross could be due to (a) AJ-type parasites. 
outgrowing AS-type in splenectomized rats, (b) a disadvanta9e 
of pyrimethamine-resistant forms in splenéctomized rats,'and 
(c) sampling. 
Clones were established from the progeny of the cross 
during early blood infections (day 3) in mice (in order 
to eliminate the possibility of establishing infections 
with red blood cells infected with more than one parasite); 
it seems unlikely, therefore, that selection against AS 
occured at this stage. 
Because of the disadvantage of pyrimethamine-resistant 
parasites in competition with sensitive forms (Hall, 1976), 
due possibly to their dependence on high levels of dietary 
PABA (Hawking, 1953), hypotheses (a) and (b) may be the 
most probable cause of the disproportionate numbers. 
However, because of the relatively small number of clones 
isolated, it is also possible that sampling may have been 
a contributory factor. 
(2) Despite the lack of AS characters, there were 32 chloroquine-
resistant to 38 chloroquine-sensitive forms in the 70 clones 
analysed. The large number of chloroquine-resistant mutants 
detected (when compared to a deficiency of markers of the AS 
parental type line) could have been due to (a) an advantage 
of chloroquine resistant parasites, independent of the other 
genetic markers, (b) association of "chloroquine-resistance" 
and "infectivity" (e.g. larger number of merozoites being 
produced), (c) transmission of resistance by means other 
than a simple Mendelian fashion, with the spread of resistance-
factors through the parasite population, (d) gene conversion 
processes, after recombination and (e) sampling. Of these 
different possibilities, sampling is the most probable as 
well as hypothesis (a) and (b) whith will be discussed later. 
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Resistance to chioroquine due to extra-chromosomal, cyto-
plasmic mutations are, I believe, improbable. Any tropho-
zoite is capable of producing male and female gametocytes 
so that any cytoplasmic character would be expected to be 
transmitted through mosquitoes. However, only reciprocal 
crosses involving the use of isolated microgametes could 
identify the true nature of cytoplasmic genetic markers. 
An absence of the expected recombinant type forms of groups 
C, D, G and H was observed. These groups coincide on 
possessing the enzyme-marker denoted LDH-2 and on being re-
sistant to pyrimethamine, and it is possible that these 
forms could have been selected against at some stage of 
the cross. 
Results from control studies (Section 11.3.2) did not suggest 
mutation events towards the production of chioroquine resist-
ance in the parental line 96AJ or back-mutations towards 
sensitivity in the parental line 411AS, thus eliminating the 
possibility of these events In accounting for the recombinant 
types of parasites obtained in the cross. 
4. 3.1 Technical considerations and further research 
Due to the significant difference in the number of parental type 
forms recovered from the products of the cross, an accurate genetic 
analysis on the frequency of recombination of the markers used was 
not possible. 	- 
Several limitations to these genetic studies exist due to the 
complex life cycle and requirements of malaria parasites. The most 
accurate analysis of a cross would be to carry out infections of 
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sporozoites of single mature oocysts which represent the product of 
a pure zygote. 	However, this technique is not yet practical. 
Crosses between the same tines should be carried out on several 
different occasions and the elimination of splenectomized rats as a 
source for higher number of gametocytes would be, possibly, advant-
ageous. Establishment of clones, by micro-manipulation of blood 
forms would also eliminate sampling errors and allow a wider scope 
of material which could be obtained at different stages of the in-
fection. 
4.4 Competition 'Studies 
4.4.1 Analysis of results 
Analysis of the fate of chloroquine-resistant forms in mixed 
populations with sensitive parasites, was carried out in the final 
section of this work. 	While pyrimethamine resistant parasites were, 
found to be at a disadvantage in competition with sensitive forms 
(Hall, 1976) chloroquine resistant mutants appeared to possess . an ad-
vantage in both blood form induced infections and after mosquito 
transmission. 
(a) 'Competition in 'blood 'form 'induced 'infections 
(1) The results, based on mass tests for resistance and for 
analysis of clones, suggested a preponderance of resistant 
forms over sensitive forms, after the 1st peak of infection 
(day 7-8). Although only two clones were obtained at day 
10 (see Table 7) a large excess of resistant forms were 
present at the 2nd peak analysis (9 resistant to 0 sensitive 
forms). 	The ratio of 9 sensitive.to.11 resistant clones 
found at day 3 suggested that the' initial mixed suspension 
contained equal numbers of parasites of each line. 
Control studies carried out simultaneously (day 3 and 2nd 
peak) showed that mutation of the sensitive parasites to 
resistance was unlikely as the explanation for the ratios 
obtained. 
(ii) When 3 different populations were studied (corresponding to 
3 different proportions of mixed resistant and sensitive 
parasites, the ratios obtained at the 2nd peak were 0:8, 
0:9 and 0:4 sensitive to resistant forms for mixtures M1 , 
M2 and M3 respectively, (see Table 8, page 49). 	Clones 
were not established at day 3 of these experiments, the R 
values for mass tests carried out at this stage being 8.25, 
13.9 and 0.13 for lines M 1 , M2 and M3 respectively. These 
figures could not be analysed statistically, mass tests 
being made only in order to obtain information on the chioro-
quine response of each mixed population, before clones were 
established. Higher R ratios were obtained at the 2nd peak 
of infection compared to day 3. 
(b) 	Competition in sporozoite-induced infections 
(1) Clones were established only at the 2nd peak of infection 
and mass tests were carried out at day 12 and at the 2nd 
peak. All the experiments showed similar results, mdi-
cating an apparent selective advantage of. the resistant 
over the sensitive forms. From clones established at the 
2nd peak, 24 were resistant and no sensitive forms were 
found (line MM), and a ratio of 6 resistant to 2 sensitive 
forms were obtained for line M. For the mass tests carried 
out 12 days after exposure to infected mosquitoes, similar 
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levels of resistance were obtained for line M and MM (R = 
2.26 and 2.34 respectively) and similar but higher values 
were obtained at the 2nd peak tests (R 24.3 and 15.6 
respectively). 
(ii) For lines M1 , M2 and M3 (See Table 10), analysed 8 days 
after exposure to infected mosquitoes, a ratio of 11:0, 
8:0 and 4:2 resistant to sensitive clones was obtained. 
Mass tests carried out for each of these lines gave R 
ratios of 23.6, 16.6 and 4.98 respectively, thus suggesting 
still a preponderance of resistant forms. 
4.4.2 Discussion of results and further research 
(a) These results were unexpected in view of the fact that mutant 
organisms are normally selected against, in the absene of drug 
pressure. 	In the case of pyriinethainine resistant P. chabaudi, this 
appeared to be the case (Hall, 1976). Other studies on the behaviour 
of resistant forms when mixed with sensitive ones have been reviewed 
by Bishop (1958a)and Walker (1964). 	Studies by Cantrell (1956) with 
Trvpanosoma (mixture of parasites was continuously passaged and tested) 
suggested elimination of the resistant parasites, in the absence of 
drug pressure. 	Studies in Bacteria have also suggested a disadvantage 
of resistant forms (Paine and Finland, 1948; Miller and Bohnhoff, 
1950). Adoutte (1974) considered that most mutated mitochondria were 
overcome by wild-type mitochondria when mixed in the same Paramecium 
cells. For chioroquine resistance in P. chabaudi, however, the re-
sistant form appeared to outgrow the sensitive in mixed infections. 
A possible explanation for these results was suggested from in 
vitro culturing of these lines. These test showed that earlier 
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schizogony occured in the chioroquine resistant population, 1 - 2 
hours before the sensitive line, tested simultaneously. Blood smears 
from in vivo controls confirmed earlier schizogony in the resistant 
line 411AS and daily slides taken at the same time suggested that this 
phenomenon was periodic (24-hour cycle) and that a delay at some stage 
in the parasite growth after merozoite invasion occured to maintain 
a 
such /periodicity. 
After the 1st peak of infection (day 7-8), red blood cells would 
be scarce and would then, probably, be invaded by resistant merozoites, 
which were produced earlier. As gametocytes originate from mero- 
a 
zoites and are produced mainly after suchJpeak, the resistant line 
would also be.at an advantage in cyclical transmission. 
(b) Another observation obtained from these studies was that relapse 
parasites of the parentálresistant.line and from the mixed populations 
xhibited a higher level of resistance (expressed as R) than those of 
day 3. 	The importance of these relapse parasites on the dissemination 
of chloroquine resistance is unknown as cyclical transmission, at this 
stage, was not carried out as these infections were of very short 
duration and low magnitude of infection. 	Soltys (1959) showed reduced 
sensitivity of an antigenically changed relapse strain of T. brucei 
towards suramin or antrycide, both in vivo and in vitro studies. 
Brown and Hills (1974) reported antigenic variation on P. knowlesi 
which was induced by antibodies. Whether host factors such as anti-
body production and its effect on the malaria parasites can induce 
changes in the parasite, which might have affected the drug response 
of these parasites is unknown. However, further experiments will be 
necessary to determine whether this observation is repeatable. 
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(c) 	Other than the suggestions already mentioned, more detailed 
competition studies should be carried out as follows: 
for these experiments to produce results which are statist- 
ically testable the number of clones established, for each 
parasite mixture, should be increased by several fold. 
oocysts obtained by dissection of mosquitoes infected with 
each separate line, resistant and sensitive, should be used 
as a source for the sporozoite-mixture studies, as oocyst 
counts in the present work were inconsistent and variable. 
the earlier schizogony of the chloroquine-resistant line 
could be investigated in a cross in order to study its 
apparent linkage with chioroquine-resistance. Such a re-
lationship would assume that during the selection of a 
chloroquine resistant mutant, either a different mutation 
had been simultaneously selected or that other effects were 
simultaneously being induced (pleiotropy). 
4.5 Variation in results 
From the evaluation of resistance (R values) during the course 
of this work, it can be seen that variation occured from one passage 
to another. Several factors may have accounted for this variation: 
(a) one of the most important factors is the variability of 
response in experimental animals. 	McLaren and Michie (1956), 
Biggers et al. (1958) and Falconer (1960) found that mice of 
the C57 inbred strain - which was used in this research - were 
more variable in their response to the drug Nembutal than F1 
hybrids from crosses between two inbred lines. The rate at 
which a particular concentration of drug is attained in the 
red cells and maintained, depends on the genotype of the 
host which controls the absorption of drugs from the ali-
mentary canal (Vessel et al., 1971). 	Other than the 
importance given to the mouse strain chosen, other factors 
which may cause variation in drug response, include the 
sex and age of the host. 	Konopka et a].. (1966) studied 
the effect of sex of host on protozoal chemotherapy and 
reported that female rodents infected with P. berghei were 
less protected by quinine than males, although opposite 
results were found with other drugs. 	Zuckerinan and Yoeli 
(1954) found that male and female rats were equally suscept-
ible to P. berghei infection and that females had more 
effective innate immunity than males. 	Ott (1969) suggested 
that the course of infection of P. chabaudi in mice was 
highly reproducible under various conditions including the 
use of young mice of approximately 20 gm in weight. 	- 
Ott (1969) and Weilde eta].. (1966) suggested that intra-
venous injection of blood forms wasmore reliable than the 
intraperitoneal route. From all the information available 
and from the results obtained in this Unit it was decided 
to use young female C57 mice as hosts, which in preliminary 
work were found to exhibit longer infections when compared 
to males of the same age, and higher infections than in 
adults of either sex. 	Intravenous injection of inocula 
was not used as a general technique for inoculation of para-
sites, because of the time difference between the beginning 
of the inoculation procedure and its end, which would have 
complicated the timing of the first drug dose. Due to 
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these factors, the standard drug test for chioroquine re-
sistance was carefully designed, treated mice being 
individually weighed on day 1 and day 4 so that drug dose 
remained constant. 
It can be seen from Table 11.3.1 in the Appendix,. that 
considerable variation in R ratios occured particularly 
among the progeny of the cross. Further work will be 
necessary to determine whether this was due to genetic 
recombination events (full resistance resulting from the 
cumulative effects of a series of mutations and not from 
a single step of considerable magnitude) or'to host effects 
such as those described above. 
In attempts to eliminate the possible host-effects in the 
drug response, in vitro culturing of parasites was devised. 
Such -technique, based on Rieckman's field test for P. 
falciparum (1968, 1971) was not equally successful with P. 
chabaudi due to the following reasons: 
a very large number of mice was necessary, in 
order to obtain a large volume of blood to dis-
tribute to the vials, 
the dissection of mice had to be carried out 
aseptically in a short length of time, 
individual parasitaemias and blood cell counts 
of the donor mice were not practical although 
necessary, as resistance was defined in terms of 
the number of trophozoites which had matured into 
- 	schizonts, for each drug dosage and relatively to 
undrugged controls. As no advantage was ob-
tamed, comparatively to the standard in vivo 
test for chioroquine resistance, in vitro 
culturing was discontinued. 
5. 	•General Conclusions 
The objective of this project was to study the genetic basis 
of drug resistance in malaria. The project was limited to one rodent 
malaria model, P. chabaudi, and to one drug, chloroquine, pyrimethamine-
resistance being used simply as a marker. 
In one P. chabaudi line (411AS) resistance was produced which 
was stable in the absence of drug pressure and through mosquito trans-
mission, the basis of which was investigated in a cross. 
Although the level of resistance developed was low, the treatment 
of 3 mg/kg for 6 days eliminated sensitive forms and is similar to the 
recommended doses for suppression of human malaria (WHO, 1973). 
There was also evidence for the development of unstable resistance 
in line 524AJ which was lost after mosquito transmission, the basis 
of which is a subject for future research. 
These results may have an important bearing on chloroquine-
resistance in P. falciparum. Chloroquine-resistance has spread 
rapidly in this species in recent years, particularly in South East 
Asia. The work described here shows that stable resistant mutants 
can be produced after low level exposure to the drug and further, 
that such mutants appear to possess an advantage over sensitive 
forms even in the absence of the drug. 
P. chabaudi may thus prove to be a more useful model system for 
70. 
P. falciparum than the more widely used P. berghei, in which the only 
chloroquine resistant lines so far developed are unstable in the ab-
sence of the drug. Other possible advantages of using P. chabaudi 
instead of P. berghei for comparative studies with P. falciparum are: 
(a) it invades mature erythrocytes rather than reticulocytes, (b) it 
possesses a synchronous schizogony, (c) its gametocytes occur predom-
inantly after the peak of infection and, (d) its sporozoites are more 
infective than those of P. berghei (Wery, 1967). 
The fact that resistance to chloroquine, in the wild, has only 
been found with P. falciparuin strains and not yet in Africa, suggests 
that innate parasite as well as host-mechanisms play an important role 
on the acquisition of resistance (Luzatto, 1974; immunity also plays 
an important role on the response to drug treatment since the parasites 
that survive the effects of the drug will be overcome by the immune 
mechanisms of the host (Bray, 1963; Luby et al., 1967). 	Reports by 
Hall and Canfield (1972) in studies comparing the response of black 
and white soldiers to infection with a resistant strain of P. falciparuin 
from Vietham have shown that the infection was less liable to develop - 
as well as less difficult to eradicate in the black population group. 
Comparative studies on strains from different origins indicate that 
the basic chloroquine sensitivity of African strains is greater than 
the strains from South East Asia or South America (Peters, 1970). 
However, other than the possible appearance of spontaneous mutants, 
one should take into account the possibility of migrants, carriers of 
gametocytes of resistant P. falciparum into areas of known sensitivity, 
-. 	and eventual persistence due to recombination phenomena. 
In a situation that can be denominated as a malaria threat, with 
the dissemination of resistant P. falciparum in South East Asia and 
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South America, the' role àf the' geneticist is an informative one. 
The mechanisms of acquisition of resistance may not be completely 
understood but the fate of those resistant parasites in mixed popu- 
lations, the stability in the absence of drug pressure and the pattern 
of cross resistance can be used in order to assist in the steps to 
take on the eradication campaigns against malaria. 
It is hoped that the results from the studies here presented 
will provide useful information that will contribute to further progress 
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Production of a P. chabaudi, AS line, resistant to chioroquine 
Date of from 
inoculation 29.4 
and 1st drug to 
dose' 	(1974) ' 	 23.1 	28.1 4.2 14.2 20.2 27.2 9.3 23.3 16.4 	23.4 10.6 	, 17.6 21.6 2.7 
Mice Number df.467(1)9  290AS4296AS -30lAS mosquitoes -P390AS -Pline deep- - 400AS-P411AS-P 451AS 	. '542AS 523ASc1ones 	 deep- 
frozen 454AS / established ' 	frozen 





Passage Number ' 	 ' 	 ' 	 1 	2 3 4 5 6 7 	, 8 ' 	 9 10 
Drug Treatment No CQ 	2ng CQ 3ma CQ , 3mg CQ No CQ No CQ 3mg CQ 3-6mg, 3mg CQ No CQ '3mg CQ 
Pressure 5 days 5 days contin- Pressure Pressure '" 	 . 	 6 days CQ 6 6 days Pressure 6 days 
uous ex- , 	 .. days 
posure 
RatioR for 
For 6.07, 	28.40 0.0 15.2 2.4 28.05 ' 	 21.82 . 31.3 55.2 514AS 
=36.3 
Ratio R ' 




(1) - Stabilate df.467 contains parasite material established from a single sporozoite induced infection 
CQ - Chloroquine 
Diagram 1.3.2. 	Production ofa P. chabaudi, AJ line, resistant to chioroguine (CQ) 
Date of inoculation 
and 1st drug dose : 7.5.74 20.5.74 29.5.74 3.6.74 13.6.74 17.6.74 
Mice number : 379(1) + 468AJ + 476AJ + 495AJ - 500AJ + 518AJ + 524AJ + line deep-frozen (df 533) 
Drug Treatment No drug 3 mg 3 mg 1.5mg 3 mg 3 mg 
Pressure CQ CQ CQ con- CQ CQ 
4 days 3 days tinuous 6 days 6 days 
expo- 
sure 
Ratio R 0.6 1.72 29.8 4.8 7.76 
Passage Number 1 2 3 4 5 
Ratio R (sensitive 
control) 0.0 0.0 0.0 
RESISTANCE ESTABLISHED 




Cjc1ica1 transmission of P. chabaudi AJ, resistant to chioroquine •(Parasite population) 
D1 * 3.10.74 10.10.74 18.10.74 30.10.74 7.11.74 19.11.74 3.12.74 10.12.74 
-  643AJ Mosquitoes 4- 681AJ 4- 693AJ 
Mice 
df.533 + 604AJ 4- 612AJ + 623AJ 630AJ + 638AJ 
number 4- 644AJ + Mosquitoes - 	 684AJ 4- 695AJ 
Drug No CQ 	3mg CQ 3mg CQ 3mg CQ 3mg CQ 	3mg CQ No CQ No CQ 3mg CQ 
Treatment Pressure 6 days 6 days conti- 6 days 	conti- Pressure Pressure 6 days 
nuous nuous 
expo- expo- 
_________ sure sure 
31.6 6.8 
R ratio 5.49 3.07 1.47 
30.8 8.4 




20.9.75 D1* 22.875 5.9.75 29.9.75 
22.9.75 
Mice 4- 997AJ - 1002AJ df. 533 ~ 983AJ - 986AJ + Mosquitoes 
Number + 998AJ + 1003AJ 
Drug No CQ 	3mg CQ No CQ No CQ 3mg CQ 








- Day of inoculation 
and 1st drug dose. 
CQ - hloroquine 
Diagram 1.3.2(b) 	Cyclical transmission of Clone 1. 
D1* 7.11.74 13.11.74 28.11.74 	10.12.74 25.12.74 3.1.75 
Mice +  Clone 1 	673AJ 
4- Mosquitoes + 714AJ + 720AJ 
644AJ + 650AJ + clones established Number + Clone 2 	677AJ (See next scheme) 
Drug 3mg CQ 3mg CQ No CQ pressure 	 3mg CQ 	No CQ No CQ 3mg CQ 
Treatment 6 days 6 days continuous 	Pressure Pressure 6 days 
exposure 




Diagram I.3.2(c) 	Cyclical transmission of clone 2. 
28.11.74 4.12.74 11.12.74 16.12.74 29.12.74 12.1.75 21.1.75 7.3.76 21.3.76 30.3.76 
Mice 
677AJ + deep frozen (df.592) + 6 blood passages under drug pressure + Mosquitoes - 	823AJ 4- 827AJ 
Number + 683AJ 	+ 703AJ 	-* 706AJ 	4- Mosquitoes + 	723AJ 	+ 724AJ 
Drug 3mg CQ 3mg CQ 3mg CQ 3mg CQ No CQ No CQ 3mg CQ No CQ No CQ 	3mg CQ 








* - Date of inoculation and 1st drug dose. 	 RESISTANCE RESISTANCE 
CQ.- Chloroquine 
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Table 11.3.1 Distribution of clones resistant to chioroquine 
established from the products of the cross between 
411AS and 96AJ (R ratios) 
Group B D F H J M 0 Q 
Total 11 0 7 0 2 1 7 4 
3.92 0.90 3.83 21.0 0.52 10.0 
5.2 0.95 11.8 0.85 10.9 
6.5 3.2 1.0 37.0 
6.61 5.0 1.70 66.5 
7.14 6.4 3.60 
8.21 11.2 13.8, 





X = 11.36 5.67 7.81 21.0 5.32 31.1 
32 clones 
Note: All clones exhibiting values of R .Z 1.0 were classified as 
resistant to treatment with chioroquine after recording 
increase of parasitaemia and regular growth rate on day 8. 
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Table 11.3.2 Control studies: 	R ratios of clones established 



























Total: 	1 24 clones 
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Table 111.3.1 Competition studies: 	R ratios of resistant forms 
established from blood infections 
DAY 3 DAY 10 2nd Peak 2nd Peak 
Lines R M R M R M .  R M1 M2 M3 
Number of 
clones 2 11 0 2 15 9 8 8 9 4 
tested 
R ratios 1.05 1.20 1.1 5.94 8.5 12.2 40.0 29.7 14.3 
9.9C 1.38 7.8 11.22 10.5 13.9 51.5 57.2 42.9 
1.40 12.50 14.16 18.7 67.2 57.8 44.5 
1.94 13.70 16.6 27.8 72.2 58.2 62.2 
4.40 14.10 19.3 50.6 73.9 62.0 
6.45 14.80 20.45 51.0 91.8 67.5 
6.90 19.10 22.8 52.6 95.0 69.5 
7.75 :. 19.80 33.3 55.3 109. 80.0 







x 	= 5.47 7.27 4.45 21.6 25.5 35.2 75.0 64.4 40.9 
TableIll. 3.2 Competition studies: R ratios of resistant forms 
established from sporozoite-induced infections. 
2nd PEAK 
Lines R M MM 
Number of 
clones 12 8 24 
tested. 
R ratios 11.7 3.70 4.19 
22.0 14.9 14.49 
23.7 19.5 14.8 
37.6 21.8 14.9 
60.2 31.87 19.1 
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.. 56..7 . 27.5 .37.5 
DAY 8 
R M1 M2 M3 
0 11 8 6 
6.0 5.4 13.1 
9.4 6.3 13.6 
9.6 12.6 34.4 




• 15.9 44.4 
16.6 
37.5 
38.1 • - 
16.6 .25.9. .29.0 
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(Repnnted from Nature, Vol. 261, No. 5561, pp.  585-586, June 1 7, 1976) 
Genetics of chioroquine 
resistance in malaria parasites 
THE resistance of the malaria parasite of man, Plasmodium 
falciparum, to treatment with chioroquine is a growing problem, 
especially in South-east Asia and South America'. It is not 
known whether the emergence of resistance is attributable to 
the selection of resistant mutants under drug pressure, to the 
spread of naturally resistant forms in the parasite population or 
to adaptation to the drug by previously sensitive parasites. In 
malaria parasites of rodents, it has been shown that resistance 
to the antifolate drug pyrimethamine arises by mutation 2 and 
that the genetic factors involved can undergo recombination 
with other markers in crosses between resistant and sensitive 
parasite lines'. Resistance to chloroquine in rodent plas-
modia seems to take several forms. P. yoelii isolates are 
innately resistant to the drug 4, whereas P. berghei and P. 
vinckei are sensitive. Stable chloroquine resistance has been 
produced in P. vinckei by drug selection in the laboratory' 
but resistance developed in this way in P. berghei is usually 
unstable in the absence of the drug 6 . 
I have investigated the genetic basis of chioroquine resistance 
in another rodent malaria species, P. chabaudi, which I believe 
serves as a useful model for P. falciparum. A chioroquine-
resistant parasite line (411 AS) of P. chabaudi was obtained in 
mice by submitting blood forms of a sensitive line to a contin-
uous low level drug pressure. Five mice (C57BL, 4-5 weeks old) 
were each injected with 106  blood forms and treated with oral 
doses of chioroquine at 2 mg kg' daily for five days from the 
day of inoculation. Mice were weighed individually at the start 
of treatment and on day four, the drug dose being adjusted if 
any change in weight had occurred. Parasites from that mouse 
which exhibited the highest parasitaemia were injected into a 
second group of mice and the treatment repeated. Five-similar 
passages were made in mice, the dose being increased to 
3 mg kg -' from the third passage. Parasites which survived this 
course of treatment were then transmitted through mosquitoes 
into mice and tested for resistance. The line survived treatment 
of 3 mg kg -' given for six days, whereas the drug-sensitive 
parent line, which had undergone a similar series of passages 
without drug pressure, was eradicated. - 
Table 1 Characterisation of 70 clones, produced by mixed infection 
of mosquitoes by lines 41 lAS and 96AJ 
LDH 6PGD Pyrimethamine Chloroquine Number of 
form s formt responses response clones 
2 3 S S 32 
3 •S R II 
2 3 R S 0 
2 3 R R 0 
2 2 S S 2 
2 2 S R 7 
2 2 R S 0 
•2 2 R R - 0 
3 3 . 	 S S 
3 3 S R 2 
.3 3 R S 2' 
3 3 R R I 
3 2 S S 
3 2 S R 7 
3 2 R S 0 
3 2 R R 4 
Total - 70 
5 LDH2 or 3, Electrophoretic forms of the enzyme lactate 
dehydrogenase. 
t6PGD2 or 3, Electrophoretic forms of the enzyme 6-phospho-
gluconate dehydrogenase. 
R, resistant to drug pressure; 5, sensitive to drug pressure. 
The stability of the resistance was tested by keeping the para-
site line undrugged for 25 blood passages (6 months), tests for 
resistance being carried out at passages 10, 15 and 25. At 
passage 15, parasites were also transmitted through mosquitoes 
into mice and tested for resistance. In all tests (3 mg kg -' for 
6 d) the parasites were found to be resistant, the resistance thus 
proving stable in the absence of drug pressure. 
The genetic basis of the chloroquine resistance was investi-
gated in a cross between line 411 AS and a sensitive line denoted 
96AJ. The two lines differed additionally in three characters. 
Line 41 lAS was resistant to pyrimethamine (15 mg kg' 
administered for four consecutive days' after inoculation of 
parasites), and possessed electrophoretic forms of the enzymes 
6-phosphogluconate dehydrogenase (6PGD-2) and lactate 
dehydrogenase (LDH-3) respectively 7 . Line 96AJ was sensitive 
to both drugs and possessed enzyme forms 6PGD-3 and 
LDH-2. 
The cross was performed using a technique described prev-
iously'. Equal volumes of parasitised red blood cells of each 
line were mixed and injected intravenously into a splenectom-
ised rat, in order to obtain increased numbers of gametocytes.-
Five days later, mosquitoes(Anopheles stephensi) were permitted 
to feed on the mixed infection. At this stage micro- and macro-
gametes from each line were formed and, as a result, both cross 
and self fertilisation occurred. Fourteen days later, the infected 
mosquitoes were permitted to feed on mice. After mosquito 
transmission, the blood forms which developed were cloned by 
dilution, and each clone examined for drug response and enzyme 
type. As controls, the parent lines 41 lAS and 96AJ were 
transmitted through mosquitoes separately, and tested for drug 
response and enzyme type in a similar way. In tests for chloro-
quine resistance, 106 parasites of each clone were injected into 
two mice,which were treated with six daily doses of chioroquine 
at 3 mg kg'. Pyrimethamine resistance was tested similarly 
using doses of 15 mg kg -' for 4 d. Electrophoretic forms of 
6PGD and LDH were detected as in the method of Carter 7 . 
Seventy clones were derived from the products of the cross, the 
characteristics of which are shown in Table 1. Clones showing 
recombinant as well as parental type characters were present. 
The numbers of clones of the two parental types were signifi-
cantly different, there being 32 of type 96AJ but only 4 of type 
411AS. This suggests that selection against line 4IIAS had 
occurred, either when the parental lines were growing together 
in the rat before mosquito transmission or between zygote 
formation and the time at which clones were established. No 
significance, therefore, can be attached to the number of clones 
found in each recombinant class. It is of interest, however, that 
the proportion ôfchloroquine resistant to chloroquine sensitive 
clones found is 32:38, suggesting that the resistant form has no 
disadvantage compared to the sensitive form. 
The results show that the chloroquine resistance which 
developed in P. chabaudi is a stable character, is inherited in 
simple Mendelian fashion, undergoes genetic recombination 
with other markers, and probably arose by mutation and selec-
tion in presence of the drug. Although the level of resistance 
developed is low, the treatment of 3 mg kg -' for six days is 
sufficient to eliminate sensitive forms, and is similar to the 
recommended doses for suppression of human malaria 8 . 
The results, therefore, may provide an explanation of how 
chloroquine resistant forms could arise in the human - malaria 
parasite, Plasmodium falciparum, in areas where the drug is 
widely used. - 
Further work is in progress in this laboratory to determine 
how the genetic factors involved can spread in populations of 
sensitive parasites. This knowledge is of particular importance 
as chioroquine resistance in P. falciparum is widespread in 
regions such as South-east Asia, but not yet in Africa. 
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